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ABSTRACT
ANALYSIS OF THE FUNCTION OF THE NUCLEAR MATRIX- ASSOCIATED
PROTEIN CID
BILADA BILİCAN
M.Sc. in Molecular Biology and Genetics 
Supervisor: Dr. Uğur Yavuzer 
July 1999, 86 pages
DNA Double-strand breaks (DSBs) are generated as intermediate stnictures during V(D)J 
recombination, as a consequence of oxidative metabolism, or can be induced by 
exogenous factors such as gamma irradiation and radiomimetic drugs. Mutational studies 
identified the serine/threonine kinase, DNA-PK, as an essential component of DNA DSB 
repair machinery. The activation of the multi-component DNA-PK complex requires 
either free DNA ends or an association with the nuclear-matrix associated protein CID, 
which facilitates the activation o f DNA-PK in a DNA end-independent fashion. The 
activation of DNA-PK through its interaction with CID, joins an increasing body of 
evidence which suggests a role for higher order nuclear organisation in the orchestration 
o f complex cellular processes such as transcription, RNA splicing, nucleotide excision 
repair, replication and double-strand DNA break repair.
In this study, the yeast two hybrid system was employed to screen a B-cell cDNA library 
to identify the interacting proteins with CID, and the interactions determined were 
further characterised. It was found that, CID  interacts specifically with the 
recombinational hotspot binding protein Translin and Translin associated factor X, 
TRAX, both in vitro and in vivo, providing evidence that C 1D may play a critical role in 
DNA repair and recombination. Interestingly, an interaction between TRAX and DNA- 
PKcs has also been identified under in vivo conditions. Tlie interaction o f TRAX with 
DNA-PKcs and C ID  indicates a connection between DNA double-strand break repair, 
recombination, and dynamic nuclear architecture.
Ill
ÖZET
NÜKLEER MATRİKS PROTEİNİ C ID ’NİN FONKSİYONUNUN İNCELENMESİ
BILADA BILİCAN
Yüksek Lisans Tezi, Moleküler Biyoloji ve Genetik Bölümü 
Tez Yöneticisi: Dr. Uğur Yavuzer 
Temmuz 1999, 86 sayfa
DNA çift sarmal kırıkları V(D)J rekombinasyonu sırasında ve oksidatif metabolizma 
nedeniyle oluşabildiği gibi, gama radyasyonu ve kanser terapisinde kullanılan ilaçlar 
sonucunda da ortaya çıkmaktadır . Mutasyon çalışmaları, bir serine/threonine kinaz olan 
DNA-PK’nın DNA çift sarmal kırıklarının onanmında önemli bir rol oynadığını 
göstermiştir. DNA-PK enzim kompleksinin aktivasyonu, serbest DNA ucu veya bir 
nükleer matriks proteini olan CİD ile etkileşimi gerektirmektedir. DNA-PK’nın CID ile 
aktivasyonu, serbest DNA ucuna gereksinim duymaması yönünden diğer aktivasyon 
mekanizmalarından aynimaktadır. DNA-PK’nın CİD ile olan etkileşimi nükleer matriks 
yapılanmasının transkripsiyon, replikasyon, DNA onarımı ve RNA işlenmesi gibi 
kompleks hücresel işlevlerin eş güdümü ve organisazyonunda önemli rol alabileceğini 
göstermektedir.
Bu çalışmada maya ikili hibrid sistemi kullanılarak bir B-lıücresi kütüphanesi taranmış, 
CID  proteini ile etkileşime giren proteinler belirlenmiş, ve bu etkileşimler karakterize 
edilmiştir. C ID ’nin in vitro ve in vivo koşullarda rekombinasyon noktalarına bağlanan 
Translin ve Translin Associated Factor X, TRAX, proteinlerine spesifik olarak 
bağlandığı gösterilmiştir. Ayrıca, TRAX’ın in vivo şartlarda DNA-PKcs ile de 
etkileşime girdiği belirlenmiştir. TRAX proteininin DNA-PKcs ve CID ile olan bu 
etkileşimi DNA çift sarmal kınk onanmı, rekombinasyon, ve dinamik nükleer matriks 
yapısı arasında bir bağlantı olduğunu göstermektedir.
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INTRODUCTION
CHAPTER I: DNA DAMAGE
Damage to genomic DNA occurs spontaneously and can be fiirther enhanced 
by environmental mutagens. We can define “damage” to DNA as of any change 
introducing a deviation from the usual double-helical structure. In this context DNA 
damage can be classified broadly into two as:
• Single base changes; Alterations that affect the sequence but not the overall 
structure o f DNA. They do not affect transcription or replication when the 
strands of the DNA duplex are separated.
• Structural distortions; Alterations that may physically hinder replication or 
transcription.
Chemical or physical mutagens induce a variety of lesions in DNA including 
base modifications, intra-strand and inter-strand crosslinking and strand breaks. If left 
unrepaired, base modifications can cause mutations and crosslinkings, and strand 
breaks that may interfere with transcription, DNA replication and chromosome 
segregation, resulting in the loss o f viability. To ensure survival, cells must be 
equipped with mechanisms to repair these DNA lesions. Proliferating cells also need 
to delay cell-cycle progression to avoid the replication or the segregation of damaged 
DNA. As a safeguard, cells of multicellular organisms have the option o f activating 
programmed cell death in response to DNA damage (Wang 1998). There are three 
categories of DNA repair. First one is excision repair, which includes both base and 
nucleotide excision repair that uses the information on one DNA strand to repair the 
damaged one. Second, mismatch repair, which occurs immediately after replicative 
DNA synthesis in S phase and relies on the parental strand to correct a 
misincorporation in the newly synthesised one. The third category is double-strand 
break repair. In this last system, three different ways are employed in joining the 
DNA ends: The first one is homologous recombination, in which the double-strand 
break on one chromosome is repaired using the information on the homologue. The 
second is single-strand annealing, and the third one is non-homologous or illegitimate 
end joining. Mammalian cells rely mostly on non-homologous end-joining activity^
and appear to rejoin the majority o f their breaks by a mechanism(s) that does not 
require extensive homology (Lewin 1997).
1.1 DNA DOUBLE STRAND BREAKS
A  specific type o f DNA damage, DNA Double Strand Breaks (DSBs), pose a 
major threat to the successful propagation and integrity of the genome. If  left 
unrepaired, they can cause cell death and, in multicellular organisms can lead to 
cancer. A variety of exogenous agents, including ionising radiation (IR) and a 
number o f anti-cancer drugs, cause DSBs, as do endogenous free radicals, the by 
products of oxidative metabolism. Furthermore, DNA DSBs occur normally as 
intermediates in V(D)J recombination, the process that helps to generate the vast 
range o f antigen-binding sites o f antibody and T-cell receptor proteins during 
mammalian lymphoid development (Gellert 1992). Thus, double-strand break repair 
is both essential for maintaining genomic integrity and for the normal development of 
immune system.
1.2 NON’HOMOLOGOUS DNA END JOINING
DNA end-joining is probably the most demanding form of DNA repair 
because the two ends are initially physically unlinked and must be brought together 
into some form of synapsis. If the break leads to the loss o f several nucleotides, the 
two ends might begin to diffuse apart; this type o f damage, therefore, begins with a 
variable distance between the two ends. While the two ends are maintained in 
synapsis, the ends must be reconfigured biochemically into a ligatable form. Small 
blocks o f terminal homology are frequently observed to be the points o f alignment of 
the two ends. Following the alignment step, excess single-stranded DNA on one or 
both strands beyond the point o f alignment may exist as flaps. If  the two ends have 
incompatible overhangs, then one or both must be trimmed; nucleases are therefore a
necessary enzymatic component. Polymerases are then needed to fill in gaps, and 
ligases are required to seal the nicks (Lees-Miller 1996).
Genetic and biochemical complementation studies have revealed that double­
strand break repair and V(D)J recombination (Figure 1) are reliant on the DNA- 
dependent protein kinase (DNA-PK). DNA-PK is an abundant nuclear protein 
serine/threonine kinase that is activated in vitro by DNA double-strand breaks and 
certain other discontinuities in the DNA double helix. DNA-PK is a multimeric 
complex with a catalytic subunit named DNA-PKcs and two non-specific DNA end 
binding proteins, Ku70 and Ku 80 (Jackson and Jeggo 1995).
Figure 1: Mechanism o f  V(D)J
recombination. A V-D joining event is shown. 
The V(D)J recombination apparatus 
recognises recombination signal sequences 
(triangles) and induces D N A  double-strand 
breaks. At their jiuiction widi coding 
sequences (rectangles). Tlie recombination- 
signal-sequence reaction intermediates are 
blunt D SB s, whereas tliose for coding 
segments are D N A  hairpins. Ligation is 
mediated by die D SB  repair apparatus.
1.3 ROLE of DNA-PK and ASSOCIA TED FACTORS in DNA NHEJ
The involvement o f DNA-PK in DSB repair became evident from analysis’ 
involving a specific series of mutant rodent cell lines. Early studies to these cells 
found them to be hypersensitive to IR and radiomimetic agents with little or no cross 
sensitivity to other types of DNA damaging agents, showed them to be defective in 
the repair o f chromosomal DNA DSBs. Subsequent cell fusion studies allowed these 
cells to be placed in three distinct complementation groups, termed IR4, IRS, and 
IR7, and the human genes complementing them were preassigned to the XRCC 
nomenclature (X-rav cross complementing, XRCC4 is the gene that complements 
cells o f IR4, XRCC5 complements IRS, and XRCC7 complements IR7) (Thompson
and Jeggo 1995). Later it was demonstrated that cells of IRS and IR7 harboured 
inactivating mutations in the genes o f Ku80 and DNA-PKcs, respectively, and 
revealed that inactivation o f Ku80 leads to a dramatic destabilisation of both itself and 
Ku70 (Peterson et al., 1995). It was therefore concluded that mutations in Ku80 and 
DNA-PKcs lead to IR sensitivity, that XRCC5 and XRCC7 encode Ku80 and DNA- 
PKcs respectively, and that DNA-PK is a crucial component o f the mammalian DNA 
DSB repair apparatus (Priestley et al., 1998).
Targeted disruption of the gene for Ku70 in mouse cells confirmed that these 
cells have a similar phenotype to IR4-7. Hence, such cells defective in Ku70 were 
designated to be IR6 and the gene for Ku70 designated to be XRCC6 (Gu et al.,
1997) . It was also noted that cells defective in IR4, 5, 6, and 7 were defective in 
coding joint formation, whereas defects in IR4, 5, and 6 affected signal joint 
formation only ( see Figure 1).
In another work, the XRCC4 gene product was cloned, and IR4 cells were 
shown to be deleted for this gene (Li et al., 1995). Subsequent studies have shown 
that this protein forms a tight and specific association with DNA ligase IV, a protein 
which itself has been revealed recently to function in DNA NHEJ (Grawunder et al.,
1998) .
1.4 Components of DNA-PK
Heterodimeric Ku protein, the DNA-targeting component of DNA-PK, binds 
without sequence specificity to double strand (ds) DNA ends, and also recognises ds 
to single strand (ss) transitions in DNA including gapped and hairpin molecules. Ku 
represents the major ds DNA end binding protein, and can be easily identified by band 
shift experiments (Blier et al., 1993). The assembly of the heterodimer is required for 
DNA binding activity and it can translocate along DNA molecules forming a 
multimeric protein-DNA complex. A putative nuclear localisation signal has been 
identified in Ku70, but not in Ku80, suggesting that the transport to the nucleus might 
take place after assembly. Although Ku has been reported to have ATPase and ATP 
dependent helicase activity, convincing ATP binding domains have not been identified
in either o f the subunit. Ku is autophosphorylated in vitro, but lacks an identifiable 
DNA-PK phosphorylation site. Also, its autophosphorylation does affect DNA-PK 
activity (Lees-Miller 1996).
DNA-PKcs is a 460-kD protein, which is stable in the absence of Ku, but the 
activation of the kinase is dependent upon the presence of DNA ends as well as Ku 
proteins, indicating that a conformational change in DNA-PKcs takes place when Ku 
becomes DNA bound. DNA-PKcs has one o f the largest cDNAs known (14 kb), and 
is a member o f phosphatidylinositol (PI) 3-kinase superfamily (Figure 2). However, 
to date no lipid phosphorylation activity has been detected (Hartley et al., 1995). 
DNA-PKcs also possesses a leucine-zipper motif, which has been found to be 
important for interaction with other proteins ( Yaneva et al., 1989; Yavuzer et al., 
1998), and an autophosphorylation site. Autophosphorylation o f DNA-PKcs is 
involved in regulation of DNA-PK activity by affecting dissociation of DNA-PKcs 
from the Ku-DNA complex (Chan and Lees-Miller 1996).
PI-3 Kinase 
Homology Domain
SLDLSCKQLASGLLELAFAFGGLCERLVSLLLNPAVLS...
Figure 2: DNA-PKcs structure. PI-3 kinase homology domain and the putative 
leucine zipper regions are indicated.
The ability o f DNA-PK to recognise ds DNA ends and to initiate a signal 
transduction pathway by phosphorylation o f relevant substrates thereby alerting the 
cell to the presence o f a DSB is a candidate mechanism by which a cell might respond 
to such DNA damage. DNA-PK has been shown to phosphorylate a lot o f proteins in 
vitro such as Spl, p53, cMyc, cJun, Hsp90, SV40T antigen, serum response factor, 
carboxy terminal o f RNA pol II (Jackson 1997). Additionally, DNA-PK can inhibit
RNA pol I transcription by phosphorylation, suggesting that one role of DNA-PK can 
be to inhibit transcription in the vicinity o f the break, thereby allowing DNA repair 
machinery to perform its function.
Currently there are numerous speculations about the precise function o f DNA- 
PK in DNA DSB repair and V(D)J recombination. For example, it has been 
suggested that DNA-PK may align the broken DNA ends or interact directly with the 
other components o f the repair machinery to target them to sites o f DNA damage. 
Alternatively, or in addition, DNA-PK might function by modifying the activity o f 
DNA repair factors by phosphorylation. It could also counteract the action of 
transcription factors or chromatin, which might otherwise interfere with the assembly 
of the DNA repair complex. In addition to these, consistent with the fact that DNA- 
PKcs is related to several factors involved in DNA damage-induced cell cycle 
checkpoint control processes, DNA-PK activation could trigger DNA damage 
signalling cascades. Figure 3 summarises the possible modes o f action. (Lees-Miller 
1996).
Figure 3: Model of possible 
interactions of DNA-PK with DNA  
and with other proteins. In all figures 
the Ku heterodimer is represented by 
the yellow circles and DNA-PKcs by 
the blue rectangle, (a) DNA-PKcs and 
Ku do not form a stable complex in 
the absence of suitable DNA staicture:
(b) The active DNA-PK complex 
forms in sequential manner on ends of 
DNA. First Ku binds with high 
affinity to a suitable DNA structure, 
followed by recruitment of DNA-PKcs 
to form the active complex. The active 
DNA-PK complex may remain at a 
DNA double-strand break site (c) or 
translocate to internal DNA sequences
(d) . In addition, DNA-PK may bind 
directly to specific internal DNA  
sequences without requirement for 
prior assembly at DNA ends.
(e) Autophosphorylation occurs on DNA-PKcs, Ku70, and Ku80 and results in dissociation of 
DNA-PKcs from DNA bound heterodimer, (f) DNA-PK can phosphorylate either soluble or 
DNA-bound substrates (orange boxes) in vitro, (g) DNA-PK may assemble at DNA double­
strand break and tether the ends of DNA together, (h) The DNA-PK complex may act as a 
scaffold to which other proteins are recruited (Lees-Miller 1996).
Recently, it has been reported that DNA-PK activates p53 in response to 
DNA damage so that p53 can bind to specific DNA sequences. As phosphorylation 
o f p53 (at serines 15 and 37) by DNA-PK induced by ionising radiation prevents 
MDM2 from inhibiting p53-dependent transactivation, the action o f DNA-PK on p53 
serves tv^o purposes: It activates p53 DNA-binding while blocking its inactivation by 
M DM 2(W oo etal., 1998)
Besides being regulated through its interaction with DNA and Ku subunits, 
DNA-PK activity and function is regulated by a variety of other mechanisms.
Interestingly, DNA-PK is present at relatively high levels (1% o f HeLa cell nuclear 
protein) and its levels do not appear to be regulated throughout the cell cycle and 
despite its activity is induced upon DNA damaging agents, its levels do not show 
major alterations in response to DNA damaging agents. These observations led to the 
idea that DNA-PK may act as a damage sensor rather than as an inducible 
downstream effector (Lee et al., 1997).
Although DNA-PK levels are constant during cell cycle, its activity is 
regulated in a cell-cycle dependent manner, with peaks of activity found at the 
Gi/early S phase and again at the G2 phase in wild type cells. The period o f the 
G]/early S phase DNA-PK activity correlates with an increased hypersensitivity to 
gamma-irradiation and a DNA DSB repair deficit in synchronised scid pre-B cells. 
However no difference is observed in the capacity of the repair o f DSBs at G2 o f scid 
cells when compared with wild-type cells, and scid cells remain permanently arrested 
in G2. These findings suggest that DNA-PK may provide an activity, distinct from its 
activity required for DNA DSB repair, that is necessary for DNA-damaged cells to 
traverse a G2 checkpoint (Lee et al., 1997).
The most interesting mode o f DNA-PK regulation is its inactivation during 
programmed cell death and upon viral infection. During apoptosis, DNA-PKcs is 
specifically cleaved by caspase-3 or a caspase-3 like protease with subsequent loss o f 
its kinase activity. This DNA-PK inactivation is probably to prevent signalling from 
or repair o f the degraded genomic DNA that is formed during the latter steps o f the 
apoptotic pathway (Song et al., 1996). In a different study, it has been demonstrated 
that DNA-PKcs is degraded upon herpes simplex virus type infection of mammalian 
cells. Thus suggests that inhibiting DNA-PK function aids virus replication and/or 
packaging. (Lees-Miller et al., 1996)
1.5 DNA-PK and C1D
Elucidation o f the exact role o f the DNA-PK in these processes require the 
exact DNA species essential for the activation o f DNA-PK, the identification o f other
10
proteins that interact with the DNA-PK complex at the DNA break site, and 
identification o f true physiological substrates of DNA-PK. Likely substrates and/or 
interacting proteins may be other DNA end-binding proteins, or helicases, nucleases, 
or ligases that may be involved in the repair or recombination processes. Some other 
questions on the activation o f DNA-PK can be stated as whether it always needs free 
DNA ends or if an accessory protein is enough to recruit DNA-PK to DNA? Though 
Ku helps to recruit DNA-PKcs to DNA in vitro and likely to be required for 
physiological activation o f DNA-PK at damage sites, there is evidence that DNA- 
PKcs can bind to DNA and exhibit kinase activity without Ku.
To gain more insight into the functions of DNA-PK, the yeast-two hybrid 
system was applied using the 1501-1602 amino acid region of DNA-PKcs that 
contains the putative leucine zipper motif and a human B-lymphocyte cDNA library 
was screened (Yavuzer et al., 1998). The putative leucine zipper region was chosen 
as bait as leucine zippers have well documented roles in mediating protein-protein 
interactions. The screen revealed 17 clones containing overlapping sequences derived 
form the same cDNA. This protein which is termed C ID  is a ubiquitously expressed 
nuclear protein with no significant homology with any known functional protein 
domains.
in this same study, it has been demonstrated that CID  interacts specifically 
with the leucine zipper region of DNA-PKcs both in vitro and in vivo, and is also an 
efficient substrate for DNA-PK in vitro, with phosphorylation being o f similar 
efficiency to the well-characterised DNA-PK substrate p53. Moreover, CID  is 
capable o f activating DNA-PK in the absence o f free DNA ends. The importance o f 
this last finding lies in the fact that till then it was believed that DNA-PK interacts 
with free DNA ends, and therefore, is activated strongly by linear DNA but only 
weakly, if at all, by closed-circular plasmid DNA. Interestingly, CID  that is bound to 
supercoiled plasmid DNA not only activates DNA-PK to phosphorylate CID itself 
but other substrates like p53 as well.
II
1.6 Identification of the Function of the C1D Protein
The fact that interphase chromosomes and individual genes occupy distinct 
territories and sites in the interphase nucleus makes the analysis o f DNA-polypeptide 
complexes potentially involved in the three-dimensional genome organisation a 
necessity. In this context, residual polypeptides which are most resistant during DNA 
isolations are o f interest with respect to their potential involvement in the topological 
organisation o f genomic DNA.
To address this problem, monoclonal antibodies to such polypeptides were 
prepared by in vitro immunisation and used to screen a murine cDNA expression 
library. A positive cDNA (MCID) was detected encoding a polypeptide of the size 
16 kD exhibited by one of the most resistant polypeptides detectable in phenol- 
extracted DNA by '^’iodine labelling and SDS-polyacrylamide gel electrophoresis. 
Later, a homologous human cDNA (HCID) was identified in the EST-sequence 
library by sequence comparison and by complete sequencing. This cDNA encodes a 
16 kD polypeptide whose cellular counterpart is able to form phenol-stable complexes 
with DNA. This suggestion is based on the fact that phenol-extracted DNA contains 
a residual antigen o f 16 kD and that the antibodies prepared against the residual 
antigens could detect a cDNA which encodes a 16 kD nuclear polypeptide with DNA 
affinity. Immunostaining of subnuclear structures by the antiserum to the recombinant 
mouse CID protein showed that in human fibroblast cells only the cell nucleus shows 
a fibrogranular staining pattern, and cytoplasmic localisation of the antigen is 
generally nonsignificant (Nehls et al., 1998).
CID  was also identified independently by another group as a nuclear receptor 
co-represor which is expressed at high levels in adult tissues. In this study, it was 
demonstrated that CID  potentiates transcriptional repression by thyroid hormone 
receptor RevErb itt vivo, represses transcription when fused to a heterologous DNA 
binding domain, and interacts with RevErb as well as thyroid hormone receptor in 
vitro (Zamir et al., 1997).
In another study, CID  is determined to be interacting with Rac3, which is a 
small GTPase of the Rho family, members o f which have been implicated in
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tumorigenesis, cell growth/death, and organisation of the actin cytoskeleton. Many 
Rac interacting proteins or effectors identified to date have a role in cytoskeletal 
organisation. In yeast cells, CID binds to constitutively activated but not GDP-bound 
Rac3, When coexpressed with Rac3 in COS cells, CID  complexed with 
constitutively active Rac3 but not with wild-type Rac3, demonstrating that CID- 
Rac3 interactions take place />; vivo in mammalian cells and that CID  appears to be an 
effector o f Rac3 (Haataja et al., 1998).
Recently, a new study demonstrated that apoptosis is induced in various 
tumour cell lines by vector dependent over expression o f the CID  protein. CID 
protein should have a basic cellular function as it is physiologically expressed in 50 
human tissues. Cells transfected with ClD-expressing constructs show terminal 
deoxynucléotidyl transferase-mediated dUTP nick end-labelling of DNA ends along 
with morphologic changes typical for apoptotic cell death, e g. cytoplasmic 
vacuolation, membrane blebbing, and nuclear disintegration. Moreover, it is observed 
that C 1 D-dependent apoptosis is not induced in cells with no functional p53 in 
agreement with the function o f DNA-PK as an upstream activator o f p53, end- 
independent activation of DNA-PK by CID and ability o f DNA-PK activated by CID 
to phosphorylate p53 (Rothbarth et al., 1999).
1.1
CHAPTER II: THE NUCLEAR MATRIX
2.1 The Nucleus
The eukaryotic nucleus, the largest organelle, is surrounded by two 
membranes, each one a phospholipid bilayer containing many different types of 
proteins. The inner nuclear membrane defines the nucleus itself In many cells, the 
outer membrane is continuous with the rough endoplasmic reticulum, and the space 
between the inner and outer nuclear membranes is continuous with the lumen of the 
rough endoplasmic reticulum (Lewin 1997).
The major physiological function of the nucleus is to direct the synthesis o f 
RNA. In a growing or differentiating cell, the nucleus is the site o f vigorous 
metabolic activity. In other cells, such as resting mast cells, the nucleus is inactive or 
dormant and minimal synthesis of DNA and RNA takes place. Still, less is known 
about the large scale organisation o f the nucleus.
2.2 Organisation of the Nucieus and Nuciear Matrix
Mammalian cell nucleus is a three-dimensional mosaic complex of condensed 
chromatin, interchromatinic regions, nucleolar compartments, and a surrounding 
double-membraned nuclear envelope containing nuclear pore complexes. 
Interchromatinic region can be divided into euchromatin, which is actively transcribed 
portion of the chromatin, and the non-chromatin nuclear matrix, which is a dynamic 
fibrogranular matrix that radiates from the nuclear interior to the nuclear pore 
complexes. The nuclear matrix is a structure that can be isolated from interphase cells 
or metaphase chromosomes after removal of soluble proteins and histones, and 
digestion o f majority o f DNA (Berezney and Coffey 1974). The nuclear matrix has a 
tripartite structure consisting o f pore complex lamina; a peripheral lamina that forms a 
continuous structure surrounding the periphery o f the nuclear sphere with residual 
nuclear pore complexes embedded in, residual nucleoli, and fibrogranular internal 
matrix which is network made up of protein and RNA (Nelson et al., 1986).
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Nuclear matrix contains 10-25% o f the total nuclear protein and tightly bound 
DNA and RNA, Nuclear matrix proteins are the nonhistone proteins which 
compromise the nuclear matrix following the nuclease, salt, and detergent extraction 
o f isolated cell nuclei. These nonhistone proteins have a heterogeneous profile and 
include cell type and differentiation state-specific proteins as well as common proteins 
termed the nuclear matrins. Nuclear lamina has a simpler profile with lamins A, B, 
and C (60-70 kD) predominating. (Berezney et al., 1996). In contrast to the nuclear 
lamins, little is known about the nature and function o f internal nuclear matrix 
proteins.
The presence of two meters o f DNA and approximately three times as much 
protein mass in the ~500pm' volume o f a typical mammalian cell nucleus generates a 
crowded macromolecular environment, hence mammalian nucleus requires a 
structural order to conduct various processes like DNA packaging, replication and 
transcription. The nature o f this organisation must be such that:
• It must permit diversity o f function, DNA must be topographically and 
topologically partitioned into independent functional units or domains
• It must carry out complex biosynthetic processes involving nucleic acids using 
multienzyme systems, eukaryotic cells appear to favour massive biosynthetic 
enzyme complexes, must be strategically positioned with respect to DNA domains
• It must direct dramatic spatial and temporal rearrangements such as the 
segregation of genetic material during mitosis, nuclear structural elements must be 
dynamic (Nelson et al., 1986).
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Over the past several years evidence has accumulated that the nuclear matrix 
is not simply a static structure, but is rather a dynamic scaffolding system that is 
intimately associated with such fundamental nuclear processes as DNA organisation, 
DNA replication, heterogeneous nuclear RNA synthesis and processing, and hormone 
action. These findings suggest that many important nuclear events occur not in 
solution but rather in association with relatively insoluble structural components that 
are firmly bound to the nuclear matrix (Nelson et al., 1986).
For instance, it has been proposed that eukaryotic nuclear DNA is organised 
into supercoiled loops anchored at their bases to the nuclear matrix, and during DNA 
replication these loops are reeled loop by loop through fixed replication sites on the 
nuclear matrix (Vogelstein et al., 1980).
Also, fixed transcriptional complexes that synthesise RNA have been identified 
on the nuclear matrix. Some studies suggest that over 95% of newly synthesised 
hnRNA is associated with the nuclear matrix (Nelson et al., 1986).
In a relevant study, it has been demonstrated that of 11 genomic sequences 
examined, only actively transcribed genes were quantitatively bound to the nuclear 
matrix. Nontranscribed sequences are localised in the unattached loop structures and 
can be released by restriction enzyme treatment. Also, the association of the 
ovalbumin gene with the nuclear matrix is reversible when hormone is withdrawn and 
transcription ceased (Ciejek et al., 1983). Also, precursor mRNAs are preferentially 
associated with the nuclear matrix compared to mature mRNAs (Gallinaro et al., 
1983).
The spaces between the chromatin contain two types o f ribonucleoprotein 
elements, called perichromatin fibrils and interchromatin granule clusters, that have 
subsequently been functionally connected to sites of pre-mRNA transcription and 
processing (Spector 1993). Ribunucleoproteins, constituting after all abundant 
elements o f the nuclear mass, are likely to be functionally integrated elements of 
nuclear architecture. The presence o f pre-mRNA splicing activity and splicing co-
2.3 Functions of Nuclear Matrix
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factor proteins were demonstrated in nuclear matrix preparations (Blencowe et al., 
1994)
Two recent studies relating to RNA polymerase II have provided strong clues 
on dynamic nuclear structure functionally related to gene expression. Mortillaro ei al. 
(1996) reported that hyperphoshorylated form of the largest subunit of RNA 
polymerase II is associated with nuclear sites at which pre-mRNA splicing factors are 
concentrated, and was selectively retained in extracted nuclear matrix preparations 
(Mortillaro et al., 1996). Moreover, Vincent el al. (1996) demonstrated that the 
largest subunit o f RNA polymerase II is a component of ribonucleoprotein depleted 
nuclear matrix preparations, and observed that this protein is only present in these 
preparations in hyperphoshorylated form. Hyperphoshorylation of the largest subunit 
o f RNA polymerase II is a transient modification, functionally linked to the most 
active phase o f this enzyme (Dahmus 1996), and hyperphosphorylation- 
dephosphorylation cycles are known to occur for numerous other nuclear proteins 
involved in DNA replication, transcription, and RNA processing.
Newly transcribed extranucleolar RNA is preferentially localised along the 
borders and within the interchromatinic regions. Once released from the chromatin 
template, the newly transcribed RNA migrates through the interchromatinic region as 
RNP particles or fibrils toward the nuclear periphery. This suggests that nuclear 
matrix contains a network of RNP particles and/or fibrils extending from the sites of 
transcription to final release through the nuclear pore complexes. The strands or 
channels o f nuclear matrix which lead from the interior to the nuclear pore complexes 
may, therefore, represent dynamic assembly lines for the co-ordinate transcription, 
splicing, processing, and transport o f RNA.
A study employing fluorescent nuclear proteins demonstrated a non­
chromatin, internal nuclear structure in living cells. Images taken in living mammalian 
cells reveal that a green fluorescent protein-tagged splicing factor (SF2/ASF) in many 
instances leaves its nuclear sites o f high accumulation as discrete packages moving 
along relatively straight tracks (Misteli et al., 1997).
The proteins o f the nuclear matrix are among the most thermal labile proteins 
in the cell, undergoing dénaturation at 43‘'C to 45"C. Heat-shock-induced protein 
dénaturation results in the aggregation o f proteins to the nuclear matrix. As many as¡7
100 protein changes have been observed as a result o f this aggregation. Protein 
aggregation with the nuclear matrix is associated with the disruption of nuclear 
matrix-dependent DNA replication, DNA transcription, hnRNA processing, and DNA 
repair. Disruptions o f these processes lead to cell death. Nuclear matrix protein 
changes affect these processes by inhibiting DNA supercoiling ability and inhibiting 
the access to matrix-associated DNA. The nuclear matrix appears to be a target for 
the detrimental effects o f heat shock, and certain heat shock proteins serve to protect 
against these defects (Roti Roti et al., 1997).
Despite the vast amount of evidences indicating the importance of nuclear 
matrix in several cellular processes, little is known about the molecular mechanisms 
underlying these events. As being a nuclear matrix protein, CID should play a very 
important role in regulation of at least some of these important biological processes.
The available information suggests that the interaction between CID and 
DNA-PKcs may serve as a mechanism to target DNA-PKcs to a DNA molecule. 
Once DNA-PK is DNA bound and activated, it may then phosphorylate and regulate 
proteins that are directly involved in DNA repair. Alternatively, or in addition, CID 
might target DNA-PK to the nuclear matrix constitutively.
As being a nuclear matrix protein C 1D should also interact with other proteins 
apart from DNA-PK. Identification o f such proteins will not only provide valuable 
clues about the function of the CID  protein, but function o f the nuclear matrix as 
well. It is possible that CID may act as an accessory protein to recruit DNA and 
several proteins to certain regions of nuclear matrix.
Therefore, the aim o f the project is the identification o f the interacting proteins 
with CID  by yeast-two-hybrid system, and further characterisation o f these 
interactions with potential significance o f providing clues about DNA-PK, C 1D, and 
nuclear matrix function (Figure 4).
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MATERIALS AND METHODS
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CHAPTER III: MATERIALS AND METHODS
3.1 Yeast Two Hybrid System
The yeast two-hybrid system provides a relatively straight forward approach 
to understanding protein interactions. The basic protocol was developed by Stan 
Fields (Fields and Song 1989) and several different two-hybrid systems have been 
developed to study protein function since then. The garden-variety application is to 
learn about the function of a given protein by isolating proteins that interact with it, 
usually by screening a cDNA library. To conduct such an interactor hunt, a protein is 
expressed in yeast as a fusion to the DNA-binding domain o f a transcription factor 
lacking a transcription activation domain. The DNA-binding fusion protein is 
generally called the bait . The yeast strain also contains one or more reporter genes 
with binding sites for the DNA-binding domain. To identify proteins that interact 
with the bait, a plasmid library that expresses cDNA-encoded proteins fused to a 
transcription activation domain is introduced into the strain. Interaction of a cDNA- 
encoded protein with the bait results in activation o f the reporter genes, allowing cells 
containing the interactors to be identified.
2 I
DNA Binding Domain Fusion Construct:
This construct was generated by U. Yavuzer and the full length open reading 
frame o f cDNA encoding CID protein (nucleotides between 118-543) was cloned 
into the Xhol site of the multiple cloning site o f vector pBTMl 16 polystop. The bait 
vector, pBTM116 poly-stop, was also modified by U. Yavuzer from the original 
plasmid constructed by S. Fields, carries the TRPl gene and has a polylinker 
downstream of LexA coding sequence. The DNA-BD is provided by the entire 
prokaryotic LexA protein, which normally functions as a repressor o f SOS genes in 
E.coli when it binds to LexA operators.
The cDNA Library:
The cDNA library was cloned into the Xhol site located in the multiple 
cloning site o f the pACT vector (The library was kindly provided by S. Elledge). 
pACT vector carries the LEU2 gene and contains NLS-Gal4-linker unit driven by the 
ADH promoter. The library was generated by random-primed cDNA synthesis from 
human B-lymphocyte polyA+ RNA. Following second strand synthesis with RNAse 
H, pol I, and E.coli DNA ligase, the cDNA was repaired with T4 DNA polymerase 
and linkered appropriately for cloning in to the vector. Fragments were size selected 
to have insert sizes greater than 600 bp. The library was originally received in 
bacteriophage, lysed, transformed into HBlOl E.coli strain, amplified, titrated and 
purified.
3.1.1 Constructs;
2 2
L40: M ATa, his3A200, trpI-901, k u 2 -2 J 1 2 , aJe2, LYS2::(LexAop)4-H lS3, 
U R A3::(LexA op)s-LacZ  GAL4. L40 can detect weak LexA activators as histidine 
prototrophs without the use o f 3-aminotriazoIe. The expression o f the LacZ and 
HI S3 coding sequences are driven, respectively by minimal GALİ and HI S3 
promoters fiised to multimerised LexA binding sites. The reporters, LacZ and HIS3, 
are integrated to the genes URA3 and LYS2 respectively of the yeast genome.
\M K 1 0 :  M A T a . his3, lys2, trp i, leu2, U R A 3::(L exA op)s-L acZ G A IJ.
3.1.2 Yeast Strains
3.1.3 Transformation
Small Scale Transformation:
A single colony o f L40 was inoculated in 10 ml YPAD (10 g yeast extract, 20 
g peptone, 0.1 g adenine, 900 ml ddH20, autoclaved, cooled and 100 ml 20% glucose 
added) and grown overnight at 30“C with shaking at 200 rpm. 50 ml YPAD medium 
was then inoculated with overnight grown culture to produce an OD(,oo between 0.2- 
0.3 and incubated further till the ООбоо reaches 0.6-0.75. All subsequent steps were 
carried at room temperature. Yeast cells were pelleted at 2500 rpm for 10 minutes. 
After resuspending the pellet in 40 ml IxTE, cells were repelleted, resuspended in 2 
ml LiAc/TE (100 mM LiAc in 0.5xTE), and incubated at room temperature for 10 
minutes. Meanwhile 0 .1 pg o f DNA was dissolved in 8 pi ddH20 and 10 pi of 
salmon sperm DNA was added. 150 pi competent yeast cells was dispensed to DNA 
tubes, mixed by flicking. 700 pi o f lOOmM LiAc/ 40% PEG-3350/lx ТЕ was added 
and incubated at 30°C for 30 minutes on a rotating wheel. Subsequently, 88 pi of
2.3
DMSO was added, followed by a heat shock at 42"C for 7 minutes. Cells were then 
pelleted, supernatant aspirated, and pellet resuspended in 1.0 ml TE. Cells were 
pelleted once more as above, resuspended in 100 pi TE, and was plated on 
appropriate selective medium.
Large Scale Transformation:
The LexA-ClD fusion plasmid was first introduced into L40 by selecting 
growth on trpytophane(-) plates after a small scale transformation. The resulting 
strain was used for growing a 2 ml overnight culture in YC - Ura, Trp ( 1.2 g yeast 
nitrogen base without amino acids, 5 g ammonium sulfate, 10 g succinic acid, 6 g 
NaOH, 900 ml ddH20, autoclaved, 100 ml 20% glucose and all amino acids other 
than stated were added). This 2 ml culture was then used to inoculate 100 ml o f the 
same medium and incubated for another 18 hours. At the end o f this period, 1.0 1 
YPAD (pre-warmed to 30‘C ) was inoculated with the 100 ml overnight culture to 
obtain an optical density ООбоо of 0.3, and grown at 30°C 200 rpm for three hours. 
Cells were pelleted at 2500 rpm for 5 minutes at room temperature and pellet was 
resuspended in 500 ml TE. The suspension was respun and pellet was resuspended in 
20 ml 100 mM LiAc/0.5xTE, and the DNA mixture was added (1.0 ml o f 10 mg/ml 
denatured salmon sperm DNA and 500 pg o f library plasmid DNA). After mixing 
well, 140 ml of lOOmM LiAc/40%PEG/lxTE was added and incubated at 30"C for 
30 minutes. The mixture was then transferred to a sterile two litre beaker and 
covered with a foil. 17.6 ml o f DMSO was added, mixed by swirling, and heat 
shocked at 42“C in a water bath for 6 minutes with occasional swirling to facilitate 
heat transfer. After the heat shock, the mixture was immediately diluted with 400 ml
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YPA ( YPAD without glucose) and rapidly cooled down to room temperature in a 
water bath. Cells were pelleted at 2500 rpm for 5 minutes at room temperature. 
Pellet was washed with 500 ml YPA, resuspended in 1.0 1 pre-warmed YPAD, and 
incubated at 30°C for one hour with gentle shaking. 1.0 ml o f the cells was removed, 
pelleted, supernatant removed, and pellet resuspended in 1.0 ml YC without uracil, 
tryptophane, and lysine. 10 and 1 pi o f these cells were plated on YC -Ura,Trp,Leu 
plate. This measures the primary transformation efficiency which should be between 
10-100x10^ transformants. The 1.0 1 o f cells was pelleted at 2500 rpm for 5 minutes 
at room temperature, pellet resuspended in 500 ml YC without uracil, tryptophane, 
and leucine, respun and then resuspended again in 1.0 L prewarmed YC without 
uracil, tryptophane, and leucine and incubated at 30°C for 4-6 hours. The plating 
efficiency increases during this period. At the end o f the incubation period, the cells 
were pelleted at 2500 rpm for 5 minutes at room temperature, washed twice with YC 
-Trp,His,Ura,Leu,Lys, and final pellet was resuspended in 10 ml YC without 
Trp,His,Ura,Leu,Lys. Aliquots of 200 pi were plated on 144 mm plates containing 
YC without Trp,His,Ura,Leu,Lys. His+ colonies were then taken to a grid for p-gal 
analysis.
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A dry nitrocellulose filter was laid onto yeast colonies paying attention not to 
trap air bubbles. The filter was marked for orientation determination, removed and 
placed colony side up on a pre-cooled aluminium boat floating on liquid nitrogen. 
After 30 seconds, the boat was immersed in liquid nitrogen for 10 seconds. Then, the 
filter was removed, and left at room temperature colony side up till it was thawed. In 
the lid o f a petri dish, 1.5 ml Z buffer containing 15 |il o f 50 mg/ml X-gal was placed 
(Z buffer: 60 mM Na2HP04, 40 mM NaH2P04, 10 mM KCl, 1 mM MgS04, pH 7.0 ). 
One #1 Whatman filter circle was placed in the lid avoiding any air bubbles. Then, the 
nitrocellulose filter was placed on top o f Whatman filter colony side facing up. The 
lid was covered with the bottom o f the dish and was incubated at 30‘’C till it yields a 
detectable colour.
3.1.4 (î-gal Filter Assay
3.1.5 DNA Isolation from Yeast Colonies
The yeast plasmid DNA was extracted and transferred to E.coli to facilitate 
further analysis. The procedure is modified from Ward A C. (Ward 1990). 3 ml o f 
culture was grown overnight at 30"C 200 rpm with appropriate selection. 1.5 ml of 
the culture was pelleted by centrifuging at 2500 rpm for 5 minutes at room 
temperature. The pellet was resuspended in 120 pi Lysis buffer ( 2% Triton-X, 1% 
SDS, 100 mM NaCl, 10 mM Tris pH,:8.0, 1 mM EDTA). 150 pi acid washed glass 
beads and 300 pi phenol/chloroform were added, and the mixture was vortexed 
vigorously for 1 minute. Then, it was centrifuged at 13,000 rpm for 2 minutes and 
the supernatant was transferred to a clean tube. In cases where supernatant was not 
clear enough, equal volume o f phenol/chloroform was added and previous step was2(^
repeated. 2.5 volumes o f cold (-20“C) absolute ethanol was added to the supernatant, 
centrifuged at 13,000 rpm for 10 minutes. The supernatant was removed, and the 
pellet was washed with 70% o f cold (-20‘*C) ethanol, dried and resuspended in 5 pi of 
sterile ddH20 . The DNA tubes were stored at -80°C till usage.
3.1.6 Isolation of cDNA Clones
To verify the specificity o f interactions, cDNA clones have to be rescued and 
put back into yeast to check for the repetition o f interaction. Also specificity should 
be confirmed by using heterologous LexA-fusion proteins. Plasmids purified from 
yeast contain both LexA-ClD fusion plasmid and the cDNA library plasmid. To 
obtain specifically the cDNA clone, the plasmid isolated from L40 yeast strain was 
transformed into E.coli strain HBlOl which is leucine deficient, and therefore, the 
LEU2 gene from yeast complements for the leucine deficiency in bacteria.
Overnight grown HBlOl culture was diluted in 100 ml to obtain an OD6oo of 
0.2-0.3 and incubated at 37°C, 200 rpm till OD6oo was in between 0.6-0.75. Culture 
was chilled on ice for 15 minutes and centrifuged at 2500 G for 15 minutes at 4“C. 
The pellet was resuspended in 50 ml o f cold sterile 10% glycerol and centrifuged at 
4000 rpm at 4"C for 15 minutes. The pellet was resuspended in the remaining few 
drops and kept on ice. The electroporation cuvettes were chilled prior to use, and 40 
pi cell suspension and 2 pi DNA (from plasmid isolates o f yeast colonies) were mixed 
in chilled eppendorfs. The mixture was transferred to electroporation cuvettes on ice 
from one side o f the cuvette, avoiding any air bubbles. The parameters o f the pulser 
apparatus was set as follows: capacitance 20 pF, pulse controller 200 Q, gene pulser
2.50 kV. The cuvette was placed in the chamber, pulse applied, and 1 ml o f LB was
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added immediately. The cell suspension was then transferred to a 15 ml falcon tube 
with a sterile pasteur pipette, and incubated at 37“C for 1 hour. Samples were then 
centrifuged at 2500 rpm for 5 minutes, pellet was washed with 1 ml M9 [0.025 g 
proline, 7.5 g bacto-agar, 390 ml ddH20, autoclaved, 100 ml 5x M9 salt solution (30 
g Na2HP04, 15 g KH2PO4, 5 g NH4CI, 2.5 g NaCl, 1 1 dd H2O, autoclaved) and 10 
ml 20% glucose added.] medium, and re-centrifuged. Final pellet was dissolved in 
100 μ1 M9, spread on ampicilline (50 pg/ml) M9 plates, and incubated at 37‘*C 
overnight. The plasmid DNA was isolated from the colonies as described in section
J .2 .J
3 .1.7 Mating Assay
The plasmid isolated from HBlOl strain was then transformed back to L40 
yeast strain and grown on trp(+) leu(-) medium. The plasmids expressing the LexA 
fusion proteins were transformed into AMR70 (M ata). The basic mating protocol is 
as follows. Single colonies from primary positive clones rescued in L40 trp(+) leu(-) 
and AMR70/bait test strains leu(+) trp(-) are mixed separately in 5 μ1 sterile ddH20 . 
Then, 2 μ1 from each mixture is mixed, dotted on a YPAD plate and incubated at 
30“€  for 4 hours. The colony was transferred to YC -Ura, Trp, Leu plate and grown 
at 30"C for two days. This step selects for diploid growth. At the end o f incubation 
period, the plates were tested for β-gal activity as described in section 3.1.4. After 
elimination o f the false-positives, the real clones were amplified and sequenced.
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The sequences o f the real positive cDNAs were first translated to protein 
sequence using Expasy Molecular Biology Server (http://expasy.nhri.org.tw) and 
Translation Machine program at http://www2.ebi.ac.uk/translate. The translations 
were performed in three reading frames and were submitted to BLAST2 
(http://www.ncbi.nlm.nih.gov/BLAST/) for homology search using basic search 
parameters, and the match with the highest meaningfial score was taken into 
consideration. The full length nucleotide sequence of the clones were then retrieved 
from Entrez server (http://www.ncbi.nlm.nih.gov/Entrez/), and subjected to 
restriction enzyme analysis using Webcutter program, which was again running online 
on WWW (http://www.firstmarket.com/cutter/cut2.html).
3.1.8 Database Search
3 .2  Recombinant DNA Manipulation Techniques
3.2.1 Preparation of Competent Cells for Transformation and 
Transformation with Plasmid DNA - CaCb Method
50-200 ml o f LB was inoculated with 0.5 ml o f overnight culture of the 
appropriate strain of E.coli and incubated until the culture reached an OD600 o f 0.6 
0.7. The cells were pelleted by centrifugation at 3000 rpm 4“C for 10 minutes, 
resuspended in 0.4 volume o f ice cold sterile 100 mM CaCb and incubated on ice for 
1 hour. The cells were pelleted as above and resuspended in 0.5-2 ml ice cold sterile 
CaCL. The competent cells prepared by this way were kept on ice till transformation 
up to 24 hours (Cohen et al., 1972).
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DNA (less than 100 ng) was added to 150 |il competent cells, and incubated 
on ice for 30 minutes. The cells were then exposed to a 90 second heat shock at 
42°C, chilled on ice for 1-2  minutes, 800 pi Luria-Bertoni (LB) ( 1 .0% tryptone, 0.5% 
yeast extract, 1 .0% NaCl) was added and incubation continued at 37°C for one hour. 
The culture was then pelleted, resuspended in 100 pi LB, and was spread on L-agar 
plates supplemented with 50 pg/ml ampicillin and/or 25 pg/ml kanamaycin, inverted 
and incubated overnight at 37‘'C.
3.2.2 Preparation of Competent Cells for Transformation and
Transformation with Plasmid DNA - Simple and Efficient Method
250 ml o f SOB (0.5% bacto tryptone, 0.5% yeast extract, lOmM NaCl, 
2.5mM KCl, lOmM MgCl2, lOmM MgSOa, sterilised by autoclaving) was inoculated 
with appropriate E.coli strain, grown to an ODeoo o f 0.6 at 37"C shaker at 200 rpm. 
The culture was chilled on ice for 10 minutes, centrifuged at 2500 g for 10 minutes at 
4“C. The pellet was then resuspended in 80 ml o f ice-cold TB (10 mM Pipes, 55 mM 
MnCL, 15 mM CaCh, 250 mM KCl, pH 6.7, sterilised by filtration through 0.45 pm 
filter, stored at 4"C), and incubated on ice for 10 minutes. The mixture was pelleted 
as above, resuspended gently in 20 ml TB. DMSO was added to 7%, mixed gently 
and incubated on ice for 10 minutes. Aliquots o f this mixture were then immediately 
chilled in liquid nitrogen, and stored in liquid nitrogen.
For transformation with supercompetent cells, an aliquot was thawed at room 
temperature. 200 pi o f the cells was mixed with plasmid DNA (less than 100 ng) in a 
15 ml tube, and incubated on ice for 30 minutes. The cells were then exposed to a 30
second heat shock at 42°C, chilled on ice for 1-2 minutes, 800 pi SOC (SOB with 20
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mM glucose) was added and incubation continued at 37"C for one hour with vigorous 
shaking at 250 rpm. The culture was then pelleted, resuspended in 100 pi SOC, and 
was spread on L-agar plates supplemented with 50 pg/ml ampicillin and/or 25 pg/ml 
kanamaycin, inverted and incubated overnight at 37°C (Inoue et al., 1990).
3.2.3 Plasmid DNA Purification and Quantitation
Small Scale Isolation
Small scale preparation o f plasmid DNA was performed by standard methods 
based on NaOH/SDS cell lysis and potassium acetate precipitation o f cellular debris 
(Maniatis et al., 1982).
Cells were harvested by centrifugation (13,000 rpm, 3 minutes, at room 
temperature) from a 1.5 ml overnight culture o f bacteria carrying the plasmid o f 
interest. Following resuspension o f the bacterial pellet in 100 pi solution I (50 mM 
glucose, 25 mM Tris-Cl [pH 8.0], 10 mM EDTA), 200 pi solution II (200 mM 
NaOH, 1% SDS) and 150 pi solution III (3M potassium acetate, 11.5% acetic acid 
[glacial] ) was added, mixed and then DNA was extracted with an equal volume o f 
phenol.chloroform 1:1. The phases were separated by centrifugation (13,000 rpm, 5 
minutes, room temperature), and the DNA was precipitated from the aqueous phase 
by addition o f 1 ml cold absolute ethanol. After washing once with 70% ethanol, the 
pellet was dried and resuspended in 30 pi ddH20 with lOpg/ml DNase-free RNase A 
to destroy the RNA in the product.
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Medium Scale Isolation
Cells were grown in 50-100 ml LB (containing appropriate antibiotic) 
overnight to saturation and plasmid DNA was isolated by using QIAfilter Plasmid 
Midi Kit (Cat No: 10 12145, Qiagen Inc.), according to the manufacturer’s 
instructions.
DNA Puriflcation from Agarose Gel
The desired DNA bands were cut from the agarose gel under UV illumination 
and DNA was extracted from agarose gel slices by QIAquick Gel Extraction Kit (Cat 
No; 28106, Qiagen Inc.), according to the manufacturer’s instructions.
Quantification of DNA
Concentrations and purity o f nucleic acids were determined by measuring 
absorbency at 260nm and 280nm in a spectrophotometer (Beckmann Instruments 
Inc., CA, USA). The ratio between absorbance values at OD260 and OD280 was taken. 
Nucleic acid samples displaying OD260 and OD280 values in the range o f 1.8 to 2.0 are 
regarded as highly pure. A value o f OD26o=l 0 corresponds to a concentration of 
approximately 50 pg/^tl double stranded DNA, and 20 pg/pl for oligonucleotides 
(Maniatis.et al 1982.).
32
3.2.4 Restriction Enzyme Digestion of DNA
Restriction enzyme digests o f DNA were carried out in a total volume o f 20 |il 
with 5-10 units o f restriction enzyme, volume o f which was always smaller than 1/10*'’ 
o f the total reaction volume. Buffers and incubation conditions were used for each 
digest as recommended by the manufacturer.
3.2.5 DNA Ligation
DNA fragments were ligated into plasmid vectors as described in Current 
Protocols (Ausubel 1987). Prior to ligation, vector and insert concentrations were 
checked by agarose gel electrophoresis, and 1:4 vector;insert ratio maintained in the 
ligation reactions. Ligations were performed in 15 pi reaction volumes containing 0.5 
pg plasmid DNA and molar excess o f insert in the presence o f 1-4 Weiss units o f T4 
DNA ligase and standard ligation buffer supplied by the manufacturer at either room 
temperature for 4 hours or at 16"C overnight.
3.2.6 Polymerase Chain Reaction
Cyclical amplification o f target DNA sequences between a pair o f 
oligonucleotide primers is possible using the thermostable DNA Polymerase o f T. 
aquaticus (Saiki et al., 1988). A typical 50 pi reaction contained 10-100 ng o f target 
DNA, 10 pmol o f each primer, each dNTP (200 mM), and 5 pi Taq pol buffer 
(provided by MBI Fermentas), and 1 pi (10 units) Taq DNA polymerase. The 
reaction was commenced in a thermal-cycler using a pre-designed three temperature
3.3
PCR programme. When the reaction was complete, amplified DNA was assessed by 
agarose gel electrophoresis, EtBr staining and purified by gel extraction. The PCR 
products were digested with the appropriate restriction enzymes overnight and ligated 
into plasmid vectors accordingly.
3.2.7 Bacterial Strains
Strain Genotype Usage Source
M15 F. Nal''. Stf’. rif. lac. ara', gal. purification of recombinant Villarejo and
(pREP4) mtr. recA", uvF proteins with pQE vectors Zabin 1974
DH5a F- supE44 hsdRl 7 recAl gyrA96 
endAl thi-1 relAl deoR lambda-
a recA" host for propagation and 
storage of plasmids
Cold Spring 
Harbour Labs.
HBlOl F- supE44 lacYl ara-14 galK2 xyl- 
5 mtI-1 leuB6proA2 deltafmcrC- 
mrr) recA13 rpsL20 thi-1 lambda
leu deficient strain used to rescue 
library plasmids
D.E. Ish- 
Horowicz
M 15 strain carrying the pREP4 plasmid, which carries the lad  gene whose 
product represses the transcription o f the pQE promoter, was used for the production 
o f the recombinant proteins.
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3.2.8 Plasmids
The maps o f plasmids that were available are presented in Figures 5-10, and their 
usage is explained in relevant sections of this text.
Element Description
Optimized promoter^ 
ope lator element
Oonsists of the p h £ ^  T s  promoter and 2 Jlscqserator 
sequences, which increase the probability o f /ac repressor 
binding and ensure efficient repression of the powerful 1B 
promoter
Synthetic ribosomal 
binding site RBSII
For efficient translation
exHis^tag ceding sequence Either 5 'o r  â ' to the polylinter cloning region
Translational stop codons In all reading frames forconuenient preparatbn 
of expression constructs
Two strong transcriptional 
terminators
t<> from phage lambda, and from the rrr>& opeion of £  caii, 
to prevent read-through transcription and ensure stability of 
the expression construct
OolEt origin o# replication From pBFiâ22
3-iactamase gene (bJls} Confers am pbillin resistance
pQC-30
0x1· .i V ·  > J tn  : 53İ : l-.f l ■ ii
'I tK Ê Ê Ê i____Ty· ,
Figure 5: The pQE vector.
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Figure 6: pACT vector
HA
BuvH lisni) 
fCDR I |«9fl) 
Sac I imsi
ISM
pACT2
<111 bp
MHIiOK IIMI
4 _ .I
/VofIwtti
C/flcm
* Thi $g!W (rtti cm U  
uiftd ·< A ftiMfUf site: 
llowMtbMi^  #M HA aprutf#
1 5V44l«ipiT«MifiM liKilif»aafb»i|04r cutlair
Figure 7: pACT2 vector
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Aatli 4274
Seal 3843
Puul3723
Bglll 3475
SnaBI ^
Sphie
Padh1
Hindlll 411
LEXA
pBTM116 po^-slop 
5000 bp
SnaBI 852
MCS S;1000 E:1050 
EcoRI 
Natl 
Xhol 
Spel 
Smal 
BamHI
f  ^  Po^-stop 
Pstl
11273
Hindlll 1484
istXI1700
ECORV1714 
Xbal 1912
Figure 8: Map o f pBTMl 16 vector
CC ATG GCC GGA TCC GAA TTC CTC GACi ATC GAT TAG ACTAGTCTAAGA AATTC 
BaniHI EcoRI x h o l CTal SpcI Xbal
Figure 9: Multiple Cloning site o f the TTpLink vector
■XI
Thrombin Kinase Snial
CTG e r r  CCG C C I CCA TCT CGT CGT GCA TCT GTT GGA I ( ( CCG GCA ATT CTA GAC
I BamH!  ^ ------- 1
EcoRI
Xbal
TCC ATG GGT CGA CTC GAG CTC AAG CTT AAT TCA
I_______ I_______ L_l I___ I___ I_______ I
Ncol Sail Hindin
Xhol Sad
Figure 10: Map of pGEX TK2-P vector, and multiple cloning site in detail.
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The oligonucleotides used in polymerase chain reaction were synthesised in 
the Beckman Oligo lOOOM DNA Synthesiser (Beckman Instruments Inc. CA, USA) 
at Bilkent University, Department o f Molecular Biology and Genetics (Ankara, 
Turkey).
Sequencing Primers:
TC 238 T7-myc-pLink Forward Sequencing Primer:
CAG AAG CTG АТС ТСС GAG^'
TC 241 pQE30 Forward Sequencing Primer:
GAA TTC ATT AAA GAGGAG AAA"'
Cloning Primers:
TC 234 TRAX Full Length Forward PCR Primer:
AGAC<:rf ( GA( AAGGATCC ATG AGC AAC AAA GAA GGA TCA^'
Sail BamHI
TC 235 TRAX Full Length Reverse PCR Primer:
AGACG rCGAt GGATCCCTA AGA AAT GCC CTC TTC^'
Sail BamMl
TC 236 Translin Full Length Forward PCR Primer:
AGACGK GAf AAGGATCC ATG TCT GTG AGC GAG АТС TTC"'
Sail BamHI
3.3 Primers
TC 237 Translin Full Length Reverse PCR Primer:
 ^ AGACG ICGACGGATCCCTA TTT TTC AAC АСА AGC^ 
Sail BamHl
10
Constructs required for bacterial and yeast expression, in vitro transcription 
and translation were prepared as follows. Inserts and plasmids were digested with 
appropriate restriction enymes, run on agarose gel for concentration determination, 
ligated as described in relevant section, transformed into bacteria and isolated 
plasmids were checked by restriction enzyme digestion. From clones harbouring the 
right constructs glycerol stocks were done and midi-prep DNA was prepared. The 
constructs were further confirmed by sequencing.
3.4 Constructs
Vector Digest Insert Digest C onstruct Usage
pQ£30/XhoI CID/Sall pQESO-CID Bacterial protein 
expression and 
purification
pGEXTK2/SalI CID/Sall pGEXTK2-ClD Bacterial protein 
expression and 
purification
pBTM lI6/Xlrol CID/Sall pBTM116-ClD Yeast expression
TRAX/Sall pBTM116-TRAX Yeast expression
Translin/Sall pBTMl 16-Translin Yeast expression
NATRAX/Sall pBTMlló- NATRAX Yeast expression
pACT/XhoI CID/Sall pACT-ClD Yeast expression
pACT2/Xhol TRAX/Sall pACT2-TRAX Yeast expression
Translin/Sall pACT2-Translin Yeast expression
NATRAX/Sall pACT2- NATRAX Yeast expression
T7 -myc-pLink/BamHI TRAX/BamHI T7mycpLink-TRAX in vitro transcripticHi 
and translation
Translin/BamHI T7mycpLink-Translin in vitro transcription 
and translation
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The automated sequencing of the constructs were carried out on a ABI Prism 
377 sequencer by Birsen Cevher in Bilkent University.
3.5 Sequencing
3.6 Gel Electrophoresis
3.6.1 Agarose Gel Electrophoresis of DNA Fragments
DNA fragments were separated by gel electrophoresis using agarose at 
concentrations o f 0.8-2.0% w/v in IxTBE buffer. Samples were loaded in the 
presence o f one fifth volume o f loading dye (8% deionised formamide, IxTBE and 
0.1% bromophenol blue). Gels were stained in IxTBE containing 0. 1% EtBr, and 
were visualised by illuminating with UV light on a transilluminator at 302nm. The 
gels were then photographed by Sony Video Graphic Printer UP-890CE or captured 
with BioRad Multi-Analyst Software running on a PC and a hardcopy produced by 
Lexmark Optra laser printer.
3.6.2 SDS Polyacrylamide Gel Electrophoresis
Electrophoretic separation o f proteins under denaturing conditions was 
performed by following the methods described in Current Protocols (Ausubel 1987). 
Gels were made up to the required concentration, 10- 12%, from a 40% acrylamide 
stock solution (38% acrylamide, 2% bisacrylamide, Severn laboratories), using either 
lower or upper buffer according to the need. Polymerisation was initiated by addition
o f 1/110 volume o f 10% APS, and 1/1250 volume o f TEMED. The electrophoresis
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apparatus was assembled according to manufacturer’s instructions (E-C Apparatus 
Corporation) and setup with Tris-glycine buffer. The samples were mixed with 
appropriate volume o f 4x loading buffer, heated to 100°C for 5 minutes to denature 
proteins, centrifuged at full speed for 5 minutes, and then loaded on to gel. 
Electrophoresis was carried out at up to 250V. The gel was then removed carefully 
and stained by Coomassie Brilliant Blue (0.25% Coomassie Brilliant Blue G250, 45 
methanol, 10% acetic acid) for 20 minutes, and destained in a solution o f 30% 
methanol, 10% acetic acid, and 60% deionised distilled water for 1 -4 hours.
3 .7  Biochemical Techniques
3.7.1 Cell Growth and Induction
The specialised components o f all media were obtained from Difco 
Laboratories Ltd, and were sterilised by autoclaving.
Liquid culture of plasmid-carrying E.coli was performed in LB with 
appropriate antibiotic selection. Liquid cultures were constantly agitated in a rotary 
shaking incubator (200 rpm). When supplementing LB-agar (LB medium with 1.5% 
agar) with antibiotic, the LB-agar was melted and allowed to cool to 55"C before 
addition o f antibiotic and pouring into 10 cm diameter plastic petri dish. Plates were 
stored at 4‘’C and air-dried prior to use.
Strains o f E.coli were stored in glycerol for long term storage. Overnight 
grown cultures to saturation were mixed with sterile glycerol with a ratio o f 1 :1, 
mixed to homogeneity, and stored at -70°C until required. Bacteria were recovered
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by scraping the surface o f the frozen stock with a sterile loop and streaking onto 
appropriate medium.
Small scale induction for screening o f protein expression was performed by 
inoculating 10 ml o f LB media with 200 pi o f an overnight culture which had been 
inoculated from a colony on agar plate. The protein expression in E.coli cells 
cariying the expression plasmid was induced by the addition o f IPTG to actively 
growing cells in LB at an ODeoo of 0.6-0.7. Incubation was continued for further 4 
hours. The induction conditions were varied depending on the vector and strain being 
used.
3.7.2 Cell Harvest and Lysis
For bacterial protein expression optimisation, hourly samples o f 1 ml was 
collected, pelleted, resuspended in 100 pi sonication buffer, sonicated for 10-15 
seconds four times at maximum power avoiding any froth. The samples were then 
centrifuged at 10,000 rpm for 20 minutes at 4‘'C. The supernatant obtained at this 
step is the soluble protein fraction o f the lysate. The pellet, which is the insoluble 
portion, was resuspended in 30 pi sonication buffer. 15 pi and 7.5 pi samples from 
soluble and insoluble parts respectively, were then analysed by SDS-PAGE gel 
electrophoresis as described in the relevant section o f this text.
4.1
3.7.3 Protein Purification of Glutathione-S-Transferase Tagged C1D 
Protein
The pGEX vectors are designed so that foreign polypeptides can be expressed 
in E.coli in a form that allows them to be purified rapidly under nondenaturing 
conditions. Foreign polypeptides are expressed as fusions to the C terminus o f 
glutathione-S-transferase (GST), a common 26 kD cytoplasmic protein o f eukaryotes. 
The fusion protein typically remain soluble within the bacteria and can be purified 
from lysed cells because o f the affinity o f the GST moiety for glutathione immobilised 
on agarose or sepharose beads. Recovery o f the fusion protein is by elution with free 
reduced glutathione at reduced pH (Ausubel 1987).
M l5 strain OÎE.coli transformed with pGEXTK2-ClD construct was induced 
in 50 ml o f culture (LB supplemented by ampicilin and kanamaycin) with 0.2 mM 
IPTG, and incubated at 30°C for 4 hours. Cells were then harvested at 2500 rpm for 
30 minutes at 4‘*C, and then resuspended in 1 ml TBS-PMSF (Triton 1%, PMSF 
ImM, BSA 10 M-g/ml, one Complete^*^' protease tablet, TBS, store at -20“C), TBS (8 
g NaCl, 0.2 g KCl, 3 g Tris base, 800 ml ddH20, pH adjusted to 7.4, autoclaved, 
stored at room temperature). Suspension transferred to microcentrifiige tubes, 
sonicated, and centrifuged at 8000 rpm at 4“C for 30 minutes. Meanwhile, 30 |il o f 
glutathione-sepharose-4B beads (Pharmacia Biotech) were washed with 500 pi 50% 
TBS at 4"С (10 minutes rotation, 5 minute centrifuging at 2500 rpm 4’’C to remove 
supernatant) for 4 times. The supernatant from the cell lysate was then loaded on 
prewashed beads and rotated at 4°C for 20 minutes. Supernatant was then removed 
at the end o f binding step and sample preserved for check. The beads were then
washed with 500 pi o f TBS-PMSF for 4 times as described above, resuspended in 20
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|il TBS-PMSF, 4 glycerol added and stored at -20°C. Samples o f 2 pi or 5 pi from 
this mix were mixed with appropriate volume o f SDS-PAGE loading dye, boiled at 
100“C for 5 minutes, centrifuged at 13000 rpm for 5 minutes and analysed on SDS- 
PAGE gel electrophoresis.
3.7.4 GST Pulldown Assay Using Immobilised GST-C1D
Reactions according to the interactions to be studied were setup in 1.5 ml 
eppendorfs as 200 pi Z buffer ( 25 mM HEPES (pH:7.5), 12.5 mM MgCb, 20% 
Glycerol, 0.1% NP-40, 150 mM KCl, prepared in 20 ml. Complete™* protease 
inhibitor added to IX, filter sterilised and stored at 4“C), 1 pi 200 mM DTT, 5mg/ml 
BSA and 10 pi beads, and preincubated with gentle rocking for 10 minutes at room 
temperature. Then, 10 pi o f radiolabelled translation product in rabbit reticulocyte 
lysate was added to the mix , and incubated at room temperature for 1 hour with 
gentle rocking. At the end of incubation, samples were centrifuged at 2000 rpm, 
supernatant was removed, and beads were washed with 1 ml o f NETN ( 20 mM Tris 
(pH:8.0), 100 mM NaCl, 1 mM EDTA, 0.5% NP40, 1 Complete**^* protease inhibitor 
tablet, prepared in 50 ml ddH20) at 4 T  for 1-2  hours as 10 minutes rocking and 5 
minutes centrifuge at 2000 rpm to remove supernatant. Samples were then analysed 
on SDS-PAGE as described in previous section, gel was dried and exposed to film.
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3.7.5 Protein Purification by Immobilised Metal Ion Affinity 
Chromatography and in  vitro Interaction Assays
Proteins expressed by using the QIAexpress (Qiagen) pQE expression vector 
system carry a stretch of six consecutive histidine residues fused to their amino 
terminus (His-tag), 0.84 kD, which allows for affinity purification using nickel ions 
immobilised on a metal chelation resin. Elution o f the bound protein is performed by 
imidazole or by lowering the pH. Purification could be carried out under native 
conditions or, if the protein is insoluble, under denaturing conditions. The principals 
o f the purification system and the basic protocols used are described in the QIAgen 
QIAexpress Handbook (1992). As His tagged-ClD expressed in bacteria is found in 
the pellet, denaturing conditions were used for purification.
M l5 strain of E.coli transformed with pQE30-ClD construct was induced in 
50 ml o f culture (LB supplemented by ampicilin and kanamaycin) by 0.5 mM IPTG, 
and incubated at 37”C for 4 hours. The cells were harvested by centrifugation at 
4000g for 20 minutes at 4‘’C, the pellet was resuspended in Buffer B (8 M urea, 0.1 M 
NaPhosphate, 0.01 M Tris-Cl pH8.0) as 5 ml buffer B/wet gram weight o f pellet. 
The cells were then stirred in a sterile beaker for one hour at room temperature. The 
lysate was centrifuged at 10,000g for 15 minutes at 4°C, and supernatant collected. 4 
ml o f resin (Ni-NTA) was equilibrated in buffer B for 30 minutes. The equilibrated 
resin was added to the collected supernatant, stirred at room temperature for 45 
minutes, and then the mixture was loaded into a column (a 5 ml syringe plugged with 
cotton wool with a flow rate o f 10-15 ml/hour). The column was then washed with 5 
column volumes o f buffer B until the OD280 o f the flowthrough was lower than 0.01,
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and with buffer C (8 M urea, 0.1 M Naphosphate, 0.01 M Tris-Ci pH:6.3) until OD280 
of the flowthrouiih was lower than 0.01.
3.7.6 Protein Refolding
Denatured proteins were refolded by gradual dilution o f the denaturing agent 
which results in careful reformation of disulfide bridges. The column was applied to a 
linear 6 M-1 M urea gradient in 500 mM NaCl, 20% Glycerol, Tris-Cl pH 7.4 with 
one complete protease inhibitor from Boehringer Mannheim over a period o f two 
hours. The beads were then transferred to a 15 ml falcon tube, centrifuged at 2500 
rpm for 10 minutes, and excess supernatant removed. A sample from this step was 
analysed by SDS-PAGE gel electrophoresis and subsequent western blotting to 
confirm the protein purification. The Ni-NTA beads bound to the refolded protein 
was kept in the same buffer at 4“C till usage.
3.7.7 Pull-down Assays
Reactions according to the interactions to be studied were setup in 1.5 ml 
eppendorfs as 200 pi Binding buffer ( 20% glycerol, 100 mM NaCl, 0. IM TE pH8.0, 
0.1% NP40), 1 pi 200 mM DTT, 6 pi 5 mg/ml BSA, 10 pi Ni-NTA bound to the 
protein o f interest, 0-15 pi (Ipg) radiolabelled translation product. The samples were 
then incubated with gentle rocking for one hour at room temperature. The mix was 
spun, and beads were washed with 1ml o f Wash buffer(20% glycerol, 100 mM NaCl,
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0.1 M TE pH:8.0, 0.3% NP40) 4 times (10 minute incubation, centrifugation at 2500 
rpm for 5 minutes, disposal o f the supernatant). The beads were then resuspended in 
5 |il SDS-PAGE loading buffer and analysed accordingly as described in relevant 
sections o f this text.
3.7.8 Immunological Detection of Immobilised Proteins (Western 
Blotting)
Transfer of Proteins onto Membranes
After performing SDS-PAGE electrophoresis, the proteins were transferred 
from the gel to a Sigma Immobilon-P polyvinylidene difluoride membrane. The 
membrane was treated with methanol prior to transfer to increase the efficiency. The 
transfer cell was assembled according to the manufacturer’s instructions using 
appropriate transfer buffer. The transfer was performed by applying an electric field 
to the gel and the membrane vertically by BioRad TransferBlot SD that generates a 
potential difference o f 10 V for half an hour.
Immunological Detection of Immobilised Proteins
After the transfer has been completed, the membrane was washed once with 
PBS, and incubated in 50 ml blocking solution (10% non-fat dry milk,0.5% Tween-20 
in PBS) for two hours at room temperature or at 4"C overnight. The membrane was 
then incubated with solution containing the primary antibody ( 1/1000 diluted in 0.1% 
non-fat dry milk in PBST) for 1 hour, and washed four times with PBST
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(PBS+Tween) for 20 minutes each. The washed membrane was then treated with 
secondary antibody (Horse radish peroxidase (HRP) coupled) with a dilution o f 
1/5000 in the same solution as above for 1 hour, and washed again as above.
The immunodetection with HRP conjugated secondary antibody was carried 
out by using Amersham LIFE SCIENCE ECL Western blotting detection reagents, 
according to the manufacturer’s instructions. The bands were visualised by exposing 
the membrane on X-ray films.
3.7 .9  In vitro Transcription and Translation
The in vitro transcription and translation o f target proteins were carried out 
with the TNT Coupled Reticulocyte Lysate Kit o f Promega, according to the 
manufacturer’s instructions using radioactively labelled methionine (S’'^  labelled). 
Samples from the products were analysed by SDS-PAGE gel electrophoresis, and 
auotoradiography performed to visualise the bands.
3.8 Restriction Endonucieases, DNA and RNA Modifying 
Enzymes
Enzymes were obtained from GibcoBRL, except Taq DNA polymerase and 
related components from MBI, and used according to the instructions o f the 
manufacturers.
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3.9 Radiochemicals
The methionine labelled with was supplied by Amersham International.
3.10 Chemicais, Kits and Special Consumables
All chemicals were purchased from Sigma, Difco, or Carlo-Erba, plastic 
disposables from Costar, Nunc, or Greiner Scientific. Gel extraction, plasmid 
purification kits and Ni-NTA resin for histidine tagged protein purification were 
supplied by Qiagen, and TNT coupled reticulocyte lysate kit by Promega. IPTG, 
complete protease inhibitor cocktail were obtained from Boehringer Manheim, colony 
lift filter Hybond-C Extra from Amersham Life Science, X-ray films from Kodak.
3.11 Equipment
The following equiments were routinely used during this study: Automatic 
pipettes (Gilson), filter and 3MM paper (Whatman), programmable dri-block 
temperature cycler GeneAmp PCR System 9600 (Perkin Elmer), heating blocks 
(Stuarts Scientific), benchtop centrifuge (Heraus Instruments), Avanti J-251 
centrifuge (Beckman), gel tanks for agarose (E-C Apparatus Corporation), vertical 
protein gel tank (E-C Apparatus Corporation), spectrophotometer DU640 
(Beckman), power supply (BioRad), pH meter (Beckman), UV transilluminator 
(Herolab), transferblot SD (Biorad).
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3.12 Standard Solutions and Buffers
lx  Tris-boric acid-EDTA (TBE): 45 mM Tris-borate, 1 mM EDTA.
4x Lower Buffer: Tris base 90.75g, SDS 2.0g, ddH20 500 ml, adjusted to pH:8.9 
with HCl.
4x Upper Buffer: Tris base 29.50g, SDS 2.0g, ddH20 500 ml, adjusted to pH:6.8 
with HCl.
SDS-PAGE Runnig Buffer: lOx stock- Tris 63.20g, Glycine 40.Og, ddH20 IL.
Working solution: 100 ml lOx stock, 5 ml 20% SDS, IL ddH20.
SDS PAGE sample Buffer: 8% SDS, 400 mM DTT, 200 mM Tris-Cl pH:6.8,
0.02g.
Bromophenol blue, 2 ml glycerol, total volume 5 ml, store at -20"C
DTT IM: 3.09g in 20 ml o f 0.01 M sodium acetate pH:5.2, filter sterilised, stores at -
20T .
Phosphate Buffered Saline (PBS): 150 mM NaCl, 16 mM Na2HP04, 4 mM 
NaH2POa, pH;7.4.
Sonication Buffer: 50 mM Na-phosphate buffer pH:7.8, 300 mM NaCl.
Transfer Buffer: 48 mM Tris-base, 39 mM glycine, 0.037% SDS, 20% methanol, 1 1 
ddH20 .
TE: 10 mM Tris, 1 mM EDTA.
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4.1 Introduction
The information gathered to date indicates that DNA-PK is heavily involved in 
non-homologous DNA end joining and V(D)J recombination, hence a critical 
component in DNA double strand break repair not only for maintaining genomic 
integrity, but also for the normal development of the immune system. In spite of the 
huge body of information gathered, molecular mechanisms o f DNA-PK activity and 
its physiological targets still remain to be determined. The available information 
suggests that the interaction between C ID  and DNA-PKcs may serve as a mechanism 
to target DNA-PKcs to a DNA molecule. Once DNA-PK is DNA bound and 
activated, it may then phosphorylate and regulate proteins that are directly involved in 
DNA repair. Alternatively, or in addition, CID  might target DNA-PK to the nuclear 
matrix constitutively.
As being a nuclear matrix protein CID  should also interact with other proteins 
apart from DNA-PK, Identification of such proteins will not only provide valuable 
clues about the function o f the CID  protein, but function o f the nuclear matrix as 
well. It is possible that C ID  may act as an accessory protein to recruit DNA and 
several proteins to certain regions o f nuclear matrix.
Therefore, the interacting proteins with CID  were identified by yeast-two- 
hybrid system, and a subset of these interactions were further characterised which has 
a potential significance o f providing clues about DNA-PK and nuclear matrix 
function.
CHAPTER 4: RESULTS
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4.2 Yeast Two Hybrid Screening
In order to identify the interacting proteins with CID, a human B-lymphocyte 
cDNA library was screened using C ID  which was expressed as a DBD-LexA fusion 
protein (provided by Dr. Yavuzer, this fusion is referred as LexA-ClD hereafter), 
LexA-ClD was then introduced into the yeast reporter strain L40 that contains both 
the HIS3 and LacZ genes under the control o f LexA operators. Importantly, L40 
containing LexA-ClD is His and expresses no detectable p-galactosidase activity, 
indicating that the C ID  protein is transcriptionally inert when fused to LexA.
Strain L40 containing LexA-ClD was transformed with a human B- 
lymphocyte cDNA library in the vector pACT. A total o f ~lxlO* transformants were 
obtained, o f which -3x10’ were capable o f growing on medium lacking histidine. O f 
these, 280 were found to produce elevated P-gal activity. After elimination o f false 
positives by use o f other LexA fusion proteins (linked to proteins Lamin and 
Daughterless) as baits, 120 o f the transformants were identified as containing cDNAs 
that conferred a His+, LacZ+ phenotype in a fashion that was specific to L40 cells 
expressing the LexA-ClD fusion protein. The cDNA expression vectors from 80 of 
these transformants were rescued, sequenced, and a homology search was carried out 
as described in relevant sections. The general scheme o f screening and results 
obtained are summarised in figures 11 and 12 respectively.
Besides the unidentified sequences, the remaining cDNAs were grouped into 
five o f which one group was comprised o f CID. This finding can be accepted as a 
positive control since CID homodimerisation had been reported previously. The 
other most interesting cDNA belonged to a recently identified gene which encodes
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Translin associated factor X, TRAX (accession X95073). TRAX is a ubiquitously 
expressed protein which has 28% identity with Translin protein (accession 
NM_004622), which is a recombination hotspot binding protein seen in many 
chromosomal translocations. Although, Translin was not detected as an interacting 
protein in our screen, as it is found in close association with TRAX, we decided to 
clone and analyse Translin along with TRAX.
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Figure 12; Summary of the Yeast Two Hybrid Screen
4.3 Alignment of TRAX cDNAs with Full Length TRAX
The initial homology search was performed using online BLAST2 programme 
working on servers o f National Biotechnology Information via WWW. The TRAX 
clone having the longest cDNA was then aligned against full length TRAX using 
ClustalW programme via WWW .
The alignment is shown in Figure 13, and the sequence of this clone was 
observed to contain no deviations from the documented full length, and was used for 
interaction assays as N-terminus deleted TRAX, and will be referred as NATRAX 
hereafter.
«:7
4.4 Amplification of the Full Length Open Reading Frames of TRAX 
and Translin from cDNA
cDNA isolated from a hepatocellular carcinoma cell line (provided by Dr. 
Yakicier) was used as template for PCR amplification of full length open reading 
frames o f TRAX and Translin. The reaction was set as described in relevant section 
o f Materials and Methods part, using the following programme;
30 c\’dcs
94»C
3'
-► 94«C—► 55®C —*“72®C
r  r  2'
-> 720C 
10'
Figure 14 shows the result o f the first round PCR.p-actin was used as a 
positive control. The expected sizes for the fragments were 686 base pairs for 
Translin, and 872 base pairs for TRAX: Fragments with expected sizes were detected 
for both o f them, though very slight amplification for TRAX. Therefore, a second 
round PCR wassetup using the TRAX PCR product from the first run. Figure 15 
depicts the result o f the second PCR, with an amplification of the expected size.
s«
1018 bp 
506 bp
1018 bp 
506 bp
Figure 14: First round PCR of TRAX 
and Translin by using TC234/TC235 and 
TC236/TC237 respectively.
Lanes
1. Marker
2. Negative Control
3. TRAX
4. Translin
5. (3-Actin control
Figure 15: Second round PCR of TRAX 
using the product from the first run and 
primers TC234/TC235.
Lanes
1. Marker
2. TRAX
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4.5 Cloning of the PCR Products of TRAX and TransHn into the 
Yeast and Bacterial Expression Vectors
The PCR products were run on 1.5% agarose gel, and purified by using 
Qiagen Gel Extraction kit. Vectors and inserts were digested with appropriate 
restriction enzymes, ligated, and transformed into supercompetent E.coli DH 5a cells 
as described in relevant sections of this text. The resulting clones were checked by 
restriction enzyme digestion, below in Figure 16, a sample digest result is presented.
VECTOR DIGEST EXPECTED F1C\GMENTS fbn)
Transliii-T7pLink Xhol 352, 164, 77
'rraiislin-TTniycpLink Xhol 352, 164, 77
TRAX-T7pIJnk BaniHI 808
TRAX-T7pLink Ndel/EcoRI 77
TRAX-pACT Ndel/EcoRI 850
Figure 16: Sample digest result (Unit is in basepair.)
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4.6 In vivo Interaction Assays
Having cloned the full-length open reading frames o f both TRAX and 
Translin, the interactions with heterologous proteins as well as DNA-PKcs was 
investigated. The protein pairs o f which interactions to be assayed, were expressed as 
either activation domain ( in pACT) or DNA binding domain fusion (in pBTMl 16), 
and transformed into yeast strains o f different mating types, L40 (Mata), AMR70 
(Mata). Mating assay was then performed to analyse the interactions.
Figure 7 shows the result o f the mating assay. The first point to note is the 
interaction between CID proteins. This result (Figure 17, 5a) can be regarded as a 
control as C ID  dimérisation has been reported previously (Yavuzer et al., 1998). The 
second control is provided by the demonstration o f the TRAX-Translin heterodimer, 
as this interaction was also previously determined (Aoki et al., 1997) (Figure 17, 2b,c 
and 3b,c). The identification of the homodimerisation of TRAX protein (Figure 17, 
2d and 3d) as strong as heterodimerisation o f this protein with Translin is, however, a 
novel finding, along with the determination o f an interaction with DNA-PKcs (Figure 
17, 4d). On the other hand, N-terminal deleted TRAX (NATRAX) shows weak 
dimérisation with the full length TRAX (Figure 17, 2e and 3e), and does not display 
interaction with DNA-PKcs (Figure 17, 4e). Another point to note is the weaker 
interaction o f the full length TRAX with CID, compared to NATRAX (Figure 17, 
compare 5e and 5d). This observation suggests a regulatory role or inhibitory effect 
o f the N-terminus o f the TRAX protein, which will be discussed later. Translin 
protein, besides dimerising with TRAX, also displayed a weak interaction with CID
protein (Figure 17, 5b,c). Overall, all the interactions observed are proved to be
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specific, as no (3-gaI activity has been detected with heterologous proteins Lamin and 
Daughterless, and DNA-binding domainLiexA) alone.
DBD Fusion
i f  ' 
^  ^  1 ,
C ID -. i' /'
Áv
.’y
AD T r a n s lin
Fusion T r a n s lin
T R A X #
—  N A T R A X
a
b
(I
c
Figure 17: In vivo interaction assay
4.7 \n vitro Interaction Assays
Having demonstrated the in vivo interactions with full-length proteins, the 
interaction between TRAX and CID was decided to be confirmed under in vitro 
conditions.
4.7.1 Purification of GST-C1D Protein Under Nondenaturing Conditions
To this end, CID  was initially expressed in bacteria as an N-terminus GST 
tagged fusion protein, and the optimal induction conditions for GST-CID was 
determined to be 4 hours o f induction with 2mM IPTG at 37"C. Purification was 
carried out as described in Materials and Methods, using the affinity o f the GST 
group o f the recombinant protein to glutathione immobilised on sepharose. The 
purified protein was not eluted, instead analysed directly on 10% SDS-PAGE gel 
electrophoresis. Figure 18 depicts the purification result which shows that the 
majority of the purified proteins are mainly GST and GST-CID with equal 
proportions, with expected sizes of GST 27.5 kD and GST-CID 43.5 kD. After 
optimising the induction and purification conditions o f GST-CID protein, GST-pull­
down assays were performed. GST-CID was immobilised on glutathione beads and 
in vitro transcribed and translated TRAX and Translin were passed through with 
various binding and washing conditions. However, CID  interacted with neither 
Translin, nor TRAX (Data not shown.). Considering that the purified GST-CID 
recombinant protein was not a very good substrate for DNA-PK as well (Yavuzer et 
al., 1998), it was possible that the interaction was hindered due to the large size o f the
GST epitope. Therefore, CID  was expressed with a smaller epitope (His tagged) 
and pull-down assays were performed on Ni-NTA column.
83.0 kD 
49.4 kD
45.0 kD
29.0 kD 
20.4 kD
7.0 kD
Figure 18: Purification o f GST-CID fiision protein. Lane 1 is the protein size 
marker, lane 2 and 3 are purified proteins o f 2 pi and 5 pi respectively from E.coli 
transformed with pGEXTK2 only. Lane 4 is the supernatant from GST induction 
only. Lanes 5 and 6 are samples o f 2 pi and 5 pi respectively from E.coli transformed 
with pGEXTK2-ClD. Lane 7 is a sample from the unbound protein fraction after 
purification.
4.7.2 Small Scale Induction of the His Tagged C1D Protein
For bacterial protein expression, pQE30-ClD construct was prepared and
transformed into M l5 cells (pREP4) with CaCb method. In order to optimise the 
expression of the His-CID protein, and to determine its cellular localisation in Ml 5 
cells, several colonies were selected and subjected to different induction conditions. 
Figures 19a and 19b show the results o f the optimal induction for His-CID protein 
achieved with 0.5mM IPTG at 37”C with an induction period of 4 hours. When
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Figures 19a and 19b are compared, it is observed that the majority o f the expressed 
protein is insoluble.
29.0 kD
20.0 kD
7.0 kD ^
Figure 19a: Small scale induction o f the His-CID protein with 0.5mM IPTG at 37"C- 
soluble portion
Lanes 2-5 are M l5 transformed with pQE30 only, hourly samples o f 1-4"' hour.
Lanes 6-9 are M15 transformed pQE30-ClD, hourly samples o f 1-4"' hour.
Lane 10 is M l5 transformed with pQE30-ClD, uninduced, sample taken at 4"' hour.
1 2 3 4 5 6 7 8 9 10
29.0 kD
20.0 kD
Figure 19b; Small scale induction o f the His-CID protein with 0.5mM IPTG at 
37"C- insoluble portion
Lanes 2-5 are M l5 transformed with pQE30 only, hourly samples of 1-4"' hour.
Lanes 6-9 are M l 5 transformed pQE30-ClD, hourly samples of 1-4"' hour.
Lane 10 is M l5 transformed with pQE30-ClD, uninduced, sample taken at 4"' hour.
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4.7.3 Purification of His Tagged C1D Protein Under Denaturing Conditions
Purification was carried out as described in Materials and Methods, based on 
the principal o f the affinity o f histidine residues to Ni ions. The recombinant CID 
protein expressed by the pQE30-ClD vector, has 6 consecutive histidine residues 
fused to its N-terminal domain, which facilitates the protein’s binding to the Ni ions 
immobilised to NTA resin. The Ni-NTA immobilised protein was not eluted, but 
instead re-folded by applying a urea gradient between 6-1 M concentration over a 
period o f two hours.
The purity and the protein content o f the purification was checked with SDS- 
PAGE, taking samples from beads after re-folding step. Figure 20 depicts the 
immobilised CID protein displaying the same size profile with the small scale 
induction result.
To confirm that the purified protein was indeed CID , a western blot was 
performed following the SDS-PAGE using the conditions described in Materials and 
Methods (Section 3.7.8). Figure 21 shows the result o f the western blot, in which the 
purified protein is recognised specifically by the antibody raised against CID.
6 6
Figure 20: Ni-NTA immobilised CID. Lane 1 protein size marker in kD. Lane 2 and 
3 are Ni-NTA immobilised His-CID loaded as(.ilg and lOpg respectively.
Figure21: Ni-NTA immobilised CID western blot result. Lane 1 protein size marker 
in kD. Lane2 and 3 Ni-NTA immobilised CID protein loaded as lOpg and Ipg 
respectively. Probe is anti-C lD  antibody.
A7
4.7.4 In vitro Transcription and Translation
To conduct the pulldown assay, TRAX and Translin proteins were in vitro 
transcribed and translated using the TNT Reticulocyte Lysate Kit o f Promega in a 
total volume o f 25pl. The proteins were radioactively labelled using’S-methionine.
Samples o f 3 pi from the products were run on a 12% Acrylamide gel to 
check the reaction. The gel was dried on a gel drier, and exposed to film. As seen in 
Figure 22, the IVTT products are of expected sizes (TRAX 32 kD, Translin 25 kD), 
and the rabbit reticulocyte lysate does not produce any product (lane 4) which shows 
the specificity o f the products.
Figure 22: in vitro transcription and translation o f TRAX and Translin 
proteins. Lane 1 protein size marker in kD. Lane 2 Translin, lane 3 TRAX, and lane 
4 negative control.
A«
4.7.5 Ni-NTA Pull-down Assay
After obtaining the TRAX and Translin proteins, binding assay was performed 
in 1.5 ml microcentrifiige tubes on refolded, Ni-NTA immobilised CID protein as 
described in detail in relevant section. Following the binding assay, the samples were 
analysed on 12% acrylamide gel. Figure 23 shows that C ID  protein interacts with 
TRAX and Translin under in vitro conditions. This interaction is specific as there are 
no binding to beads, as demonstrated in lanes 7 and 8. In accordance with the in vivo 
results, TRAX bound to CID stronger than Translin (Figure 23, compare lanes 1 and 
2). Also, when CID was incubated with TRAX and Translin in the same reaction, 
simultaneous binding o f each protein was observed. In order to quantitate the amount 
o f proteins bound to the immobilised CID, the image was captured by BioRad 
GelDoc2000 system, and the intensity of the bands were analysed by using the 
software Bio-Rad Multi-Analyst running on a PC and the graph and data obtained is 
shown in Figure 24. As clearly observed, 85.8% of the input TRAX bound to CID 
whereas only 42.2% of the input Translin interacted with CID. Although it looks as 
if TRAX and Translin bound to CID  in a competitive manner (46.9% of input TRAX 
vs 29.17% o f input Translin bound to CID), it is not possible to conclude about the 
mode o f interaction between TRAX-Translin and CID before obtaining the in vivo 
results.
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Figure 23: Ni-NTA pulldown.
Lanes:
1. TRAX with immobilised His-C 1D
2. Translin with immobilised His-C 1D
3. TRAX and Translin with immobilised His-CID
4. TRAX input
5. Translin input
6. Protein size marker inkD
7. TRAX with beads only
8. Translin with beads only
70
Figure 24: Quantitation ofNi-NTA pull-downs.
Lane 1: C lD  bound TRAX 75.94 cmxcount 
Lane 2: C ID  bound Translin27.31 cmxcount
Lane 3, peak 1; C ID  bound TRAX-Translin, first band, TRAX 41.57 cmxcount 
Lane 3, peak 2: C ID  bound TRAX-Translin, second band, TransUi8.85 cmxcount 
Lane 4: Input TRAX 88.50 cmxcount
Lane 5. Input Translin 64.62 cmxcount
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CHAPTER 5: DISCUSSION
DNA repair is essential for successful maintenance and propagation o f genetic 
information. One o f the DNA lesions that can have deleterious effects within the cell 
is the double-strand DNA breaks. These lesions can occur as a consequence of 
oxidative metabolism, or are induced by gamma irradiation or radiomimetic 
chemicals. DNA DSBs are also generated as intermediate structures during V(D)J 
recombination that mediates the rearrangement o f immunoglobulin and T-cell 
receptor genes (Gellert 1992). The repair o f DNA DSBs is therefore not only 
important for the maintenance o f genomic integrity but is also essential for the normal 
development o f the immune system.
In eukaryotes two DNA DSB repair pathways have been identified that differ 
in their requirements for DNA homology. DNA DSB repair by homologous 
recombination, which is primarily used by yeast species, results in precise repair o f the 
DNA lesion but requires a homologous sequence. In vertebrates, however, non- 
homologous DNA end joining is generally employed and the two ends of the DNA is 
joined independent o f terminal DNA sequence homologies (Critchlow and Jackson 
1998). Mutational studies also identify the NHEJ pathway as the primary means for 
resolving the intermediates formed during V(D)J recombination. Furthermore, 
genetic and biochemical complementation studies revealed that DNA-dependent 
protein kinase plays an important role in NHEJ pathway. DNA-PK is a multiprotein 
complex consisting o f a ~465 kD catal3d:ic subunit termed DNA-PKcs and a DNA- 
binding component composed of two associated polypeptides called Ku70 and Ku80. 
Defects in any one of the components of DNA-PK cause radiosensitivity and inability ^
to perform V(D)J recombination (Jackson and Jeggo 1995). Despite the progress 
achieved in this area, molecular mechanisms underlying the role o f DNA-PK in 
lymphocyte development and NHEJ /// vivo remain poorly understood. Although it 
was believed that in vitro activation o f DNA-PK requires free DNA ends, it has been 
demonstrated that DNA-PK can also be activated in the absence of DNA ends 
through interaction with the nuclear-matrix associated protein, CID. Furthermore, 
CID  can be phosphorylated very efficiently by DNA-PK (Yavuzer et al., 1998). The 
interaction between DNA-PK and a nuclear-matrix associated protein is particularly 
interesting because the nuclear matrix provides the structural framework for 
nuclear/chromatin organisation, and has been shown to associate with several nuclear 
processes including replication, transcription, RNA splicing, topoisomerase activity, 
nuclear excision and DNA DSB repair (Nelson et al.,1986 ; Koehler and Hanawalt 
1996).
In this study, as a first step towards identification o f the function of C 1D in 
DNA repair/recombination and other cellular processes, the yeast two hybrid system 
was applied to screen a human B-lymphocyte cDNA library for polypeptides 
interacting with CID. The results revealed that the positive cDNAs isolated fall into 
five distinct groups. Among these, one group is the CID  itself, consistent with the 
fact that CID  can homodimerise. Two further groups of cDNAs were potentially 
interesting as they support the idea that CID  is intimately involved in DNA repair and 
recombination. Thus, in addition to cDNAs encoding ERCCl, a protein involved in 
nuclear excision repair, CID  was also found to interact with the Translin-associated 
factor X (TRAX). The Translin protein itself binds to specific sequences at the 
breakpoint junctions in many chromosomal translocations other than heptamer-
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nanomer signal sequences that are recognised by recombinases during 
immunoglobulin or T-cell receptor rearrangements.
The involvement o f Translin in leukaemia and lymphoma arising from 
chromosomal translocations and its interaction with TRAX, makes an analysis from 
cancer point o f view a necessity. Cancer is due to somatically acquired genetic 
changes and sometimes is associated with inherited predisposing mutations. There 
are three main cytogenetic changes observed in chromosomal aberrations that lead to 
tumour development. One o f them, deletions result in loss of a tumour-suppressor 
gene. The others, translocations and inversions, can be grouped as those consistently 
found in certain tumour types (specific) and those observed only in the tumour from 
one patient (idiopathic). There are two principal consequences of translocations and 
inversions. Either the gene for a T-cell receptor or an immunoglobulin protein comes 
to line near a proto-oncogene, thereby activating it, or the breaks occur within a gene 
on each chromosome involved, creating a fusion gene encoding a chimeric protein. 
The genes that are involved in these processes are often transcription factors, 
indicating the importance o f changes in transcription in tumorigenesis (Rabbitts 
1994).
Chromosomal translocations are observed frequently in cases of human 
leukaemia or lymphoma. Immunoglobulin (Ig) and T-cell receptor (TCR) 
recombinase is involved in such aberrant rearrangements by recognising the heptamer- 
nonamer signal sequences present on both affected chromosomes. But there seemed 
to exit different target sequences that are not resembling the signal sequences for 
Ig/TCR recombinase. Information that back up this idea came from a study which 
identified novel conserved sequences, GCAGA[A/T]C and CCCA[C/G]GAC, at the
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5' flanking sites o f the breakpoint junction o f chromosome 8 and chromosome 1 in T- 
acute lymphoblastic leukaemia (ALL) patients carrying t(8,14)(q24;ql 1) and 
t(l,14)(p32;l 1) translocations involving the TCR 5-chain locus. This conserved, non- 
random target sequence was a candidate for another protein-mediated site-specific 
recombination event. Further studies led to the identification o f a new protein with a 
general binding activity to these consensus target sequences at breakpoint junctions, 
and named the protein as Translin (Translocation) (Aoki et al., 1995). The Translin 
cDNA encodes a protein of 228 amino acids with a predicted molecular weight of 
26.180 kD. Purified Translin protein migrates as a single band o f approximately 27 
kD under reducing conditions and 54 kD under nonreducing conditions, indicating 
that Translin polypeptides are held together by disulphide bonds. Experiments to 
determine the cellular localisation o f Translin showed that the native form o f Translin 
was present in the cytoplasm o f cell lines o f various lineages, whereas in lymphoid cell 
lines with rearranged Ig and TCR loci it was solely found in nucleus. This finding 
suggests a mechanism for active nuclear transport o f Translin and an association of 
this protein with lymphoid specific processes such as Ig/TCR rearrangement (Aoki et 
al., 1995).
Moreover, when a nonhematopoietic cell line (HeLa) was treated with the 
DNA-damaging agents, mitomycin C and exposide, the active nuclear transport of 
Translin was induced. This result indicates that DNA damage initiates a signalling 
pathway, resulting in active nuclear transport of Translin, which implies additional 
roles for this protein in DNA repair and apoptosis.
In situ hybridisation and physical mapping of somatic cell hybrids allowed the 
localisation o f the gene to the human chromosome 2q21.1 (Aoki et al., 1997).
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The predicted amino acid sequence o f Translin contains two relatively basic 
regions (amino acids 56-64 and 86-97). The carboxy-terminal region o f the molecule, 
between 177-212 amino acids, harbours a putative leucine zipper region. The native 
form o f Translin is a ring-shaped octamer with a molecular weight o f approximately 
220 kD, which is responsible for its binding to target sequences situated only at 
single-stranded DNA ends (Kasai et al., 1997).
To investigate the functional significance o f Translin binding at breakpoint 
junctions, interacting proteins with Translin were identified by yeast-two-hybrid 
screening. The screen identified an associated 33 kD protein partner with 28% 
identity to Translin. The protein is named as TRAX (Translin associated factor X), 
and contains putative lecuine zipper region between amino acids 73 and 108, and a 
bipartite nuclear targeting sequence at N-terminus. TRAX interacting specifically 
with Translin, may be responsible for selective nuclear transport of Translin protein 
lacking any nuclear targeting motifs (Aoki et al., 1997).
In our study it is demonstrated that both TRAX and Translin interact 
specifically with CID  both />/ vitro and /// vivo, although the Translin/CID interaction 
is weaker than TRAX/CID interaction. Two novel findings are worth to note, first 
homodimerisation o f TRAX, and second, determination o f the hi vivo interaction of 
TRAX with DNA-PKcs. Surprisingly, the N-terminal deleted TRAX was identified 
to be homodimerising weakly with full length TRAX and exhibiting a stronger 
interaction with CID  when compared to its full-length. Furthermore, the N-terminal 
deleted TRAX was not able to interact with DNA-PKcs. These observations about N- 
terminal deleted TRAX may imply a regulatory/inhibitory role related with the N-
terminus o f the protein.
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The clues that indicates the association o f DNA-PK with nuclear matrix to 
perform its functions, and involvement of Translin in processes like DNA repair, 
replication, recombination, and regulation o f its nuclear localisation along with these 
observations altogether suggests a role for CID  both in recombination and DNA 
repair, as well as raises new possibilities o f connections between DNA repair and 
recombination.
One model to account for these observations would be that DSBs are initially 
recognised by Ku70/Ku80 which then recruit DNA-PK catalytic subunit. Signals 
resulting from the presence o f the DSB would also direct the association and nuclear 
localisation o f a TRAX-Translin complex. The induction o f CID expression in 
response to DNA damage and the association of CID  with DNA-PKcs targets the 
DSB to the nuclear matrix. Ku70/Ku80 helicase activity enables the DSB to be 
recognised by a Translin/TRAX complex, with CID  again playing a role in stabilising 
the interactions by interacting with TRAX.
Although this is a highly speculative model, it provides a framework for 
further work directed towards elucidating the functions of the CID, TRAX, and 
Translin proteins which will yield fundamental insights into the mechanisms operating 
in DNA repair and recombination.
78
5.1 PERSPECTIVES
In this study, the interaction of CID  with TRAX and Translin was 
demonstrated under in vitro and in vivo conditions, as well as in vivo interaction of 
TRAX with DNA-PK , though weak, was also identified. The next step in the course 
o f the experiments should be the demonstration o f interactions in mammalian systems 
as well. For this purpose TRAX and Translin proteins can be expressed as HA tagged 
in mammalian cells and immunoprécipitation can be carried out accordingly. After 
ultimate conformation of the interaction results, the experiments should be designed 
to unreveal the functional significance o f these interactions. The homologs of both 
TRAX and CID proteins are identified in yeast strain S. cerevisiae, hence knockout 
experiments both alone and as double knockouts will provide information on 
physiological role o f these proteins. After obtaining the knockouts, they can be 
assayed for plasmid repair capacity and radiation sensitivity. Furthermore, to observe 
the role o f these proteins in recombination, targeted disruption o f CID  and TRAX in 
highly recombigenic eukaryotic cells can be performed. Along with these experiments, 
the interaction domains o f CID-TRAX, CI D-DNA-PK and TRAX-Translin can be 
mapped and the requirements for nuclear localisation o f Translin can also be 
determined.
All these experiments will provide the necessary information to prove or 
disprove the previously stated hypothesis, hence shed more light on molecular 
mechanisms in which these proteins are involved like recombination and DNA repair.
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